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OVERVIEW OF RELATED LITERATURE 
Introduction 
Candida albicans is an opportunistic pathogen with a 
wide range of infectious capabilities. Infections vary from 
localized to systemic, and are potentially fatal. The 
immune response to ~- albicans varies directly with the type 
of ~. albicans infection. Localized infections are 
controlled by polymorphonuclear leukocytes (PMNs) and later 
by macrophages (Smith, 1985). Deep seated infections are 
contained by PMNs as well (Wilton and Lehner, 1981). 
However, multiple cell populations have been implicated in 
the immune response to systemic fungal infection, including 
T lymphocytes (Mahanty et al., 1988). The evidence for 
absolute involvement of any one effector population is 
inconclusive. Animal models with genetic defects in various 
lymphoid populations have failed to elucidate a precise 
anti-~. albicans mechanism (Mahanty et al., 1988). 
Therefore, it is possible that alternative cell populations, 
activated by the immune response to ~. albicans, may be 
responsible for and contribute to the actual immunological 
and protective response to ~. albicans. 
1 
2 
immune Response to C. albicans. 
Host defense against infection with ~. albicans is 
mediated by both phagocytic cells and aspects of classical 
cell-mediated immunity (Mahanty et al., 1988). Other immune 
cell populations have also been assessed for their role in 
host defense activity against ~. albicans including B 
lymphocytes (Smith, 1985) and natural killer (NK) cells 
(Zunino and Hudig, 1988). However, the relative 
contribution of each cell population in protection against 
specific forms of candidiasis remains to be elucidated. 
A. Role of phagocytic cells 
Invasive infections of ~. albicans are the result of 
hyphal forms which are too large to be ingested by 
phagocytic cells but have been shown to be damaged by them 
via extracellular mechanisms (Diamond and Haudenschild, 
1981; Hurtrel et al., 1980; Diamond and Krzesicki, 1978). 
The proposed anti-fungal mechanisms for these cells are the 
production of reactive oxygen intermediates such as hydrogen 
peroxide, super oxide anion, hydroxyl radical, and singlet 
oxygen (Nathan et al., 1983). Oxygen-independent killing of 
macrophages against a variety of targets has been attributed 
to a number of secreted substances including arginase, 
cytolytic protease, thymidine, complement cleavage products, 
macrophages cytotoxin, lysosomal cationic proteins, and 
tumor necrosis factor (Smith, 1985; Cleary and Marciano-
3 
Cabral, 1986). As a consequence, these cells have been 
implicated as the primary means by which invasive infections 
of ~· albicans are limited (Ashman and Papadimitriou, 1987) . 
Further evidence for the important role of phagocytic cells 
comes from studies in which T lymphocyte-deficient nude mice 
were found to be relatively more resistant to infection than 
normal animals due to increased macrophage activity (Rodgers 
and Balish, 1980). Despite the decrease in T lymphocyte 
activity, nude mice possess an enhanced NK activity and a 
normal level of lymphokine activated killer (LAK) cell 
activity (Hasui et al., 1989). Therefore, the resistance to 
infection in nude mice may not be an exclusive consequence 
of increased macrophage activation. It is possible that 
alternative cell populations, such as NK and LAK, may serve 
to mediate host protection against the fungus in the nude 
mouse as well as in the normal host environment. 
B. Role of T cells 
Thymus-dependent, cell-mediated immunity provides 
protection against ~. albicans as evidenced by enhanced 
susceptibility to candidiasis in thymectomized mice (Mahanty 
et al., 1988). Further evidence is displayed by patients 
with chronic mucocutaneous candidiasis (Wilton and Lehner, 
1981), malignancies (Bodey, 1986), and immunodeficiency 
syndromes (Smith, 1985), who often display defective 
delayed-type hypersensitivity (DTH) reactions to ~. albicans 
antigen. T lymphocytes from a majority of these patients 
show no responsiveness to g. albicans antigen in vitro 
(Odds, 1979) • 
In addition to the DTH response, Cenci et al. (1989) 
have suggested an important role for inflammatory L3T4+ 
lymphocytes as a cofactor of phagocytic cell activation. 
4 
The loss of L3T4+ lymphocytes significantly reduced host 
resistance to g. albicans as judged by DTH responsiveness, 
lymphokine production, and survival (Cenci et al., 1989). 
Cenci et al. (1989) have postulated that immune L3T4+ T 
lymphocytes contribute to protective immunity against 
systemic g. albicans infection through the secretion of 
cytokines which activate cells with candidacidal activity. 
However a portion of animals possess the capacity to survive 
following L3T4+ lymphocyte depletion. The authors suggest 
alternative mechanisms may provide protection under 
conditions for which the activity of this T lymphocyte 
subset is reduced. 
c. Role of B cells 
A role for B lymphocytes in protection against fungal 
infection is not established (Hector et al., 1982). 
Although some host protection can be transferred with immune 
serum, B lymphocytes and their products play a minor role in 
the protective host response to ~. albicans (Piccolella §.t 
al. I 1980) • 
5 
o. Role of natural killer cells 
Natural killer (NK) cells have been shown to interact 
with certain fungi. In vitro, cells with both functional 
and phenotypic characteristics of NK have been shown to bind 
to and inhibit the growth of Cryptococcus neoformans as well 
as to inhibit the growth of Paracoccidiodies brasiliensis 
(Nabavi and Murphy, 1985; Murphy and McDaniel, 1982; Jimenez 
and Murphy, 1984). In vivo, NK have been shown to mediate 
growth inhibition of cryptococcus neoformans (Hidore and 
Murphy, 1986). Other investigators have failed to 
demonstrate human NK anti-fungal activity against g. 
albicans (Djeu and Blanchard, 1987) . Those investigators 
found that enriched human LGL possessed no innate activity 
against g. albicans. The LGL population could not be 
activated by low levels of IL-2 to inhibit g. albicans 
growth although cytotoxicity for the human NK susceptible 
tumor cell line K562 was enhanced. Activated LGL supernate 
contained the capacity to enhance PMN function against g. 
albicans. These data suggest that this LGL population did 
not mediate direct anti-g. albicans activity but rather 
functioned in an indirect manner by inducing the release of 
TNF which then activated PMN anti-g. albicans activity (Ojeu 
et al., 1988). 
NK cells do not appear to have a major role in 
resistance to murine g. albicans infections (Vecchiarelli et 
al., 1985). Isolated splenic NK cells show no direct anti-
g. glbicans inhibitory activity which suggests that NK may 
not mediate destruction of yeast species other than 
cryptococci (Zunino and Hudig, 1988). 
6 
severe combined immunodeficient (SCIO) mice have no 
detectable levels of immunoglobulins in their serum and 
their mature T and B lymphocytes are markedly reduced in 
number or even absent (Hasui et al., 1989). Mice homozygous 
for SCIO gene possess normal macrophage activity and an 
expanded pool of natural killer cells with normal functional 
activity (Lauzon et al., 1986). Comparisons of homozygous 
SCIO to heterozygous SCIO (phenotypically normal) BALB/c 
mice show no difference in the recovery of g. albicans from 
organs following infection. This observation suggests that 
a non-T, non-B lymphocyte may mediate anti-fungal activity 
(Mahanty et al., 1988). The exact role of T lymphocytes is 
unclear as both athymic nude mice and T lymphocyte deficient 
SCIO mice both possess normal or enhanced activity against 
g. albicans which is in contrast to studies demonstrating a 
T lymphocyte requirement for immunity. Whether the 
protection is mediated by activated macrophages or by an 
activated lymphocyte population is unknown. Both nude mice 
and SCIO mice possess normal LAK activity (Hasui et al., 
1989) . 
Infection with Candida and c. albicans. 
A. Virulence of Candida and g. albicans 
7 
Although antigenic variation of ~. albicans and 
variation in virulence have been described (Ausiello et al., 
1989), it is changes in the host which contribute most to 
susceptibility to infection with ~- albicans (Wilton and 
Lehner, 1981; Meunier, 1989). Numerous species of candida 
are pathogenic, including ~. albicans, Candida tropicalis, 
Candida krusei, and Candida parapsilosis. In general, ~. 
glbicans is the species most associated with invasive 
candidiasis following fungemia (Meunier, 1989). Invasive or 
systemic candidiasis has a mortality rate of over 70% in 
immunosuppressed patients and is difficult to both diagnose 
and treat (Matthews and Burnie, 1989). 
Systemic candidiasis is the most serious form of 
candidiasis. It is recognizable by invasive infection 
involving the parenchyma of two or more visceral organs 
including heart, kidney, spleen, lung, and brain among 
others. Histologically, the lesions in systemic candidiasis 
resemble small abscesses composed of a mixture of PMNs and 
mononuclear cells (Luna and Tortoledo, 1985). 
B. Candidiasis in immunosuppressed patients 
A variety of immunocompromised patients are susceptible 
to Candida infections. A number of factors contribute to 
the increasing frequency of fungal infections in these 
patients. In patients with cancer undergoing combination 
chemotherapy, the patient becomes debilitated, malnourished 
and host defense mechanisms are impaired. The patients 
become highly susceptible to infection and resistant 
microorganisms, such as fungi, can cause superinfection 
(Bodey, 1966). Fungal infections are especially prevalent 
among children with acute lymphocytic leukemia who 
experience prolonged periods of neutropenia due to the 
disease or its therapeutic treatment (Gold, 1984). 
Infections caused by Candida species are the most common 
fungal diseases in immunocompromised patients (Hawkins and 
Armstrong, 1984). Fungi cause 21% of the fatal infections 
in patients with acute leukemia, 13% in patients with 
lymphoma, and 6% in patients with solid tumors (Bodey, 
1986). Candida spp. account for a majority of serious 
fungal infections with Candida albicans the most frequent 
pathogen (Ashman et al., 1990). 
8 
Other prime candidates for life-threatening invasive 
candidal infections are those with defects in normal immune 
function, in particular patients with chronic granulomatous 
disease. Persons with profound defects in cell-mediated 
immunity, such as transplant recipients, patients with 
acquired immunodeficiency syndrome, and patients receiving 
chronic steroid therapy are also at significant risk of 
invasive candidal infection. Finally, therapeutic 
maneuvers, such as antibiotics and steroids, that compromise 
normal mucocutaneous barriers to infection will enhance ~. 
albicans colonization and predispose patients to systemic 
candidiasis (Meunier, 1989). 
Binding of c. albicans to Host Tissue. 
A primary concern of the host immune response to g. 
albicans is the mechanism by which the fungus attaches to 
host tissues. An understanding of the mechanisms which 
permit g. albicans to colonize host tissue may allow a 
further understanding of the immune recognition of g. 
albicans. The cell surface of this organism has been 
investigated because of its perceived role in virulence. 
9 
The cell wall is composed of several layers and includes the 
major antigens of the yeast cell. The cell undergoes 
significant compositional changes during conversion of yeast 
form to the hyphal form (Reiss et el., 1986). This 
phenomenon is associated with the invasiveness of the 
organism. 
Adherence of g. albicans to the mucosal epithelial 
cells is an important initial step in the process of 
colonization and invasion. Hydrophobic interactions of the 
cell wall with the endothelium are believed to be important 
in g. albicans binding to target tissues (Hazen, 1989). 
Apical growth and elongation as a compartmentalized tube 
allows for invasion of epithelial cells by direct 
penetration of the epithelial cell membrane (Braun and 
Calderone, 1978). 
10 
oespite the utilization of hydrophobic interactions, a 
more detailed mechanism for binding of ~. albicans to other 
cell populations is unknown. Bouchara et al. (1990) have 
shown that ~. albicans in the hyphal form, possess germ tube 
specific receptors for laminin which mediate its attachment 
to basement membrane. Laminin is a multifunctional 
glycoprotein which promotes the adhesion of various 
eucaryotic cell types in vitro. Specifically, laminin 
receptors have been found on cells that normally interact 
with basement membrane (Yannariello-Brown et al., 1988), as 
well as on cells that extravasate, such as tumor cells, 
granulocytes, lymphocytes and macrophages. Basement 
membranes are normally unexposed in vivo, with the exception 
of the endothelia of kidney glomeruli to which candidal 
infections seed thus serving as a source of dissemination in 
systemic candidiasis. 
The location of the laminin receptor on ~. albicans has 
been specified by electron microscopy. The receptor is 
connected to the outer f ibrillar layer of the hyphal cell 
wall. The receptor is not found on the yeast form nor on 
the mother cell of the hyphae. The binding of the hyphae 
was saturable and specific. Two types of receptors were 
found. The first had a molecular mass of 68 kilodalton {kD) 
which is similar to laminin receptors previously described 
on different cell types including tumor cells and 
endothelial cells (Rao et al., 1983; Yannariello-Brown et 
11 
al., 1988). The second receptor was a doublet of 60 and 62 
-
kD, which may correspond to a degradation product of the 
first as found in tumor cell lines (Graf et al., 1987). 
The doublet may also be related to previously described 
g. albicans proteins. Calderone et al. (1988) found that by 
further separating 70 and 62 kD proteins isolated from ~­
albicans cell wall on high-performance liquid chromatography 
that complement component C3d receptor could be isolated at 
60 kD. The complement component C3d fragment has also been 
found to bind exclusively to the hyphal form of ~. albicans 
(Eigentler et al., 1989). Another possible explanation is 
that the 68 and 60/62 doublet are related to other adhesion 
molecules. Tronchin et al. (1988) isolated four proteins 
which are involved in the adherence of ~. albicans hyphae to 
plastic. The two major proteins involved in binding were 68 
and 60 kD. Either similar proteins or functions of the same 
proteins are involved. 
Bouchara et al. (1990) found that the same components 
of 68 and 60 kD which bound laminin also bound another 
common basement membrane protein, f ibrinogen, and to some 
extend the complement component C3d. Fibrinogen, greatly 
reduced the binding of laminin to ~. albicans, suggesting 
that binding of f ibrinogen leads to a stearic hindrance of 
the laminin receptors or that binding of these two host 
proteins to hyphae may be by the same receptor (Bouchara et 
al., 1990). Fibronectin, bovine serum albumin, 
12 
transferrin, and multiple oligosaccharides did not bind the 
iaminin receptor indicating a degree of specificity. 
However, the capacity of the receptor to bind unrelated 
proteins suggests multiple biological activities for the 
receptor. The molecular mechanism of recognition of these 
unrelated host proteins by the same g. albicans receptors 
remains unclear. These data do suggest that attachment of 
~· albicans hyphae to tissue and cell surf aces may correlate 
with the presence of an extracellular matrix component which 
mediates binding to the hyphal surface. 
Due to the role phagocytic cells play in the clearance 
of g. albicans, multiple studies have assessed the mechanism 
by which these effector populations bind the fungus. The 
state of the phagocytic cell, the presence or absence of 
serum components, and the physiological state of g. albicans 
are contributing factors to cellular recognition and binding 
(Houston and Douglas, 1989). The best characterized 
interaction is that of rat alveolar macrophages which bind 
g. albicans through a mannose/N-acetylglucosamine receptor. 
This receptor is demonstrable on human peripheral blood 
mononuclear cells (PBMC) which were cultured in vitro for 
three days without lymphokines. Fresh PBMC however, do not 
possess the receptor (Stahl et al., 1980). 
Consideration must be given to the physiological state 
of g. albicans during the binding process. Growth in 
enriched media or within the host increases the production 
13 
of the outer fibril layer. An increase in the fibril layer 
will increase both the adherence and virulence of ~. 
~bicans. Phagocytic cells appear to recognize ~. albicans 
by lectin-carbohydrate interactions which promote strong 
attachment following increased fibril production (Houston 
and Douglas, 1989). Lectin-like interactions mediate 
attachment of ~. albicans to vaginal and buccal cells via 
mannoprotein fibrils on the outer cell envelope (Critchley 
and Douglas, 1987). The fibrils also promote binding to 
PMNs as well as alveolar and peritoneal macrophages by a 
related mechanism (Warr, 1980; Kolotila et al., 1987). 
Furthermore, macrophage binding to yeast depends on a 
lectin-like macrophage receptor specific for glycoproteins 
terminating in mannose or fucose residues (Stahl and Gordon, 
1982). 
The binding is not believed to be mediated by specific 
receptors but rather by a variety of factors such as the 
activation state of the cell in combination with the state 
of the host and the time course of the infection (Houston 
and Douglas, 1989). Most likely, the activated phagocyte 
recognizes a component of the cell wall through either 
lectin-type interactions, or sugar residues before 
activating its extracellular cytotoxic machinery. A similar 
recognition mechanism is possible for other non-specific 
effector populations. 
Hidore and Murphy (1989) evaluated the binding of NK 
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cells to cryptococcus neoformans. They found both 
similarities and differences in the physical and kinetic 
binding and growth inhibition of cryptococci compared with 
binding and lysis of tumor targets. Electron microscopy 
studies demonstrated that in contrast to the broad area of 
interdigitating membrane contact observed in NK cell-tumor 
cell conjugates, the contact area of NK cell-cryptococci 
conjugates is much smaller, does not appear to 
interdigitate, and is less intimate (Murphy, 1989). They 
found binding to be Mg2+ dependent. Growth inhibition was 
ca2+ and temperature dependent for both fungal and tumor 
targets. Murphy therefore suggests a similar recognition 
and effector mechanism for cryptococci and tumor cells. The 
structural differences between the fungal and tumor cell 
target would still permit intimate cell to cell interaction. 
The investigation of Murphy (1989) did not identify the 
mechanism by which NK recognizes, binds, and mediates its 
effect on ~. neoformans. Despite the binding and cytotoxic 
activity demonstrated against the cryptococci, NK cells do 
not possess anti-~. albicans activity (Vecchiarelli et al., 
1985). However, Zunino and Hudig (1988) found that ~. 
albicans inhibited the binding of NK cells to K562 tumor 
targets. 
Immunoregulation of c. albicans Infection. 
A. Suppression of the immune response 
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ouring infection, Q. albicans itself may both up-
regulate and down-regulate the immune system. Neutrophil 
function was shown by Diamond and Haudenschild (1981) to be 
impaired by substances liberated from hyphae of Q. albicans. 
Normal T-lymphocyte functions may also be impaired during 
the course of Q. albicans infections. The lack of T-cell 
reactivity to Q. albicans antigens, a characteristic of 
patients with chronic mucocutaneous candidiasis, was noted 
by Valdimarsson et al. (1973) to be occasionally reversed 
when the infection was controlled, thus suggesting the 
fungal infection induced the abnormality in lymphocyte 
function. Evidence of immunosuppression includes a decrease 
in the in vivo response to the common skin test antigens and 
suppressed in vitro proliferative responses to Q. albicans 
antigens {Cuff et al. 1989). Stobo et al. (1976) found 
generalized abnormalities in T-cell recognition of fungal 
antigens in infected patients and showed that the 
abnormality was due to the generation of suppressor T 
lymphocytes. Cuff et al., (1989) have described the 
suppressor cell to be Thy-1+, Lyt-1+, Lyt-2-, and L3T4+. 
Others have found the suppressor population to be cos+ or 
even a B lymphocyte population (Domer, 1989). The mediator 
of suppression appears to reside in the cell wall 
polysaccharide, mannan, although its exact makeup is unknown 
(Podzorski et al., 1990). The observed immunosuppression 
has been proposed to be due to factors released during the 
yeast to hyphae transition of ~. albicans (Cockayne and 
odds, 1984). 
B. Activation of the immune response 
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In murine models, it has been shown that inoculation of 
live or inactivated ~. albicans cells or purified components 
of the ~· albicans cell wall, can modulate the activity of 
the immune system. Components of other microorganisms have 
been shown to activate MHc~unrestricted cell cytotoxicity 
(Tarkkanen et al., 1986; Bonavida et gl_., 1986). ~. 
albicans induces strong anti-tumor responses in mice 
infected with heat-killed yeast and hyphae from ~. albicans 
(Kohoshis et al., 1978; Marconi et al., 1985). These 
responses are also induced by inoculating mice with either 
of the two primary components of the cell wall of ~. 
albicans, mannoprotein (GMP) or glucan (GG). NK and 
macrophage effectors are activated following administration 
of either component. GMP also induces lymphoproliferation 
and production of gamma interferon as well as the generation 
of cell-mediated cytotoxicity in PBMC (Ausiello et al., 
1988). GMP induced lytic effectors are similar to IL-2 
induced lytic effectors in potency, target specificity, and 
type of precursor cells. These data suggest that cytokines 
produced in response to the infection are involved in 
nonspecific anti-microbial resistance induced by ~. albicans 
(Vecchiarelli et al., 1989). 
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~ariability in the Murine Immune Response to c. albicans. 
The C57Bl/6 mouse is highly resistant to challenge with 
~· albicans. Other inbred murine strains are much more 
susceptible to the fungus {Marquis et g_l., 1986). The 
differential susceptibility between murine strains is not 
solely due to differences in phagocytosis and/or splenic 
clearance of the microorganism. Various murine strains 
such as C57Bl/6 (high resistance), BALB/c (intermediate 
resistance), and CBA/H (low resistance) show no correlation 
between survival following £. albicans challenge and either 
of those biological activities (Ashman and Papadimitrou, 
1987). SCID mice, deficient in T and B lymphocytes, possess 
macrophage activity which is not significantly different 
from corresponding inbred strains (Hasui et al., 1989). 
Nude mice and mice which have been thymectomized, lethally 
irradiated, and bone marrow reconstituted show no difference 
in macrophage activity or clearance of £. albicans when 
compared to normal mice (Ashman and Papadimitrou, 1987). 
A correlation does exist between the production of 
cytokines and the development of resistance to the fungus 
within murine strains. Neta and Salvin (1983) reported that 
the release of lymphokines from mice following sensitization 
with cell walls of £. albicans was under genetic control. 
They found the capacity of a murine strain to release 
cytokines in vivo parallels the capacity of that strain to 
18 
resist i.v. infection with g. albicans. g. albicans 
infected strains of mice which released high levels of IL-1 
and IFN gamma (high responder strains, such as C57Bl/6) were 
also noted to have lower tissue numbers of c. albicans than 
did those strains of mice which released low levels of 
cytokines (low responder strains, such as CJH). 
oue to the relevance of cytokine release in the 
differentiation and activation of microbicidal splenocytes, 
Vecchiarelli et al. (1989) studied cytokine production in 
the unprimed murine response to g. albicans. Using hybrid 
BALB/c x DBA/2 mice (two intermediate responder strains), 
they evaluated the pattern and kinetics of selected cytokine 
production in g. albicans infected animals. GM-CSF, TNF 
alpha, IFN gamma, and IL-1 were measured in the sera and 
spleen cell supernates of infected mice. High levels of GM-
CSF, TNF alpha, IFN gamma, and IL-1 were found six hours 
after infection. The high cytokine levels persisted for 
many days. A correlation existed between the ability of g. 
albicans to induce anti-microbial protection in vivo and 
cytokine production in vitro. These data coupled with that 
of Neta and Salvin (1983), suggest an involvement of 
cytokines in the host protective response to g. albicans in 
the mouse. 
Further evidence for the involvement of cytokines in g. 
albicans infection is demonstrated by g. albicans induction 
of TNF production by human monocytes and LGLs in vitro (Djeu 
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§:t Al· , 1988) . TNF was detected as early as eight hours 
after incubation with £. albicans. Maximal levels of TNF 
occurred between 24 h and 48 h. No priming signal was 
required. Only partial inhibition of NK activity and TNF 
induction was produced by the elimination of CD16+ (Fe 
receptor) or NKHl+ in the LGL population. Furthermore, 
antibody and complement depletion of cells positive for Leu 
1, a phenotypic marker of some NK cells, had little effect 
on £. albicans induction of TNF by NK cells. These data 
suggest a population of LGL besides NK release TNF upon 
stimulation with £. albicans. 
TNF functions as an anti-tumor agent. However, TNF is 
primarily regarded as a key product of the mononuclear cell 
response to microbial antigen involved in septic shock. TNF 
has long been known to activate phagocytic cells to enhance 
anti-microbial activity and therefore may play a role in 
microbial immunity (Philip and Epstein, 1986). Djeu et al. 
(1988) have postulated that TNF production is a normal 
response of monocytes and LGL to stimulation by fungi such 
as £. albicans. Release of TNF assists in activation of PMN 
and other effector functions to control £. albicans growth 
(Djeu et al., 1988). The effect of TNF resulting from£. 
albicans infection on other effector populations has not 
been studied. 
The release of IFN gamma in response to £. albicans 
infection is believed to activate macrophages and other 
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cellular populations which when activated by these cytokines 
acquire increased anti-fungal activity. The inhibitory 
activity of macrophages activated with IFN gamma is well 
documented (Nathan et al., 1983). Another result of IFN 
gamma release may be activation of MHC-unrestricted 
lymphocytes. IFN gamma has previously been demonstrated to 
produce a synergistic effect with low doses of IL-2 in the 
activation of MHC-unrestricted lymphocytes (Limb et al., 
1989). TNF also synergizes with low doses of IL-2 to induce 
activation of lymphocytes with MHC-unrestricted cytotoxic 
activity. This activity requires the presence of IL-2 (Blay 
et al., 1989). Therefore, IFN gamma and TNF can cooperate 
in the activation of lymphocytes to enhanced cytotoxic 
activity. 
Human IFN gamma directly inhibits g. albicans germ tube 
formation (Kalo-Klein and Witkin, 1990). The mechanism is 
unclear. However, the authors speculate that specific 
receptors exist for IFN gamma and that the interaction of 
IFN with the g. albicans yeast form inhibits CAMP production 
and therefore hyphal formation (Kalo-Klein and Witkin, 
1990). By inhibiting yeast to hyphal transition, IFN gamma 
may directly alter the pathogenic potential of g. albicans. 
Besides host production of IFN gamma and TNF, an 
essential part of the immune response to microbial infection 
is the production and release of IL-2. Ausiello et al. 
(1988) exposed human PBMC in vitro to g. albicans and at 
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dailY intervals the release of IFN gamma and IL-2 as well as 
cytotoxicity for the tumor cell target, K562, was 
determined. They found that IFN gamma and IL-2 were 
produced first, after which significant anti-K562 
cytotoxicity was generated. Although IFN gamma production 
peaked prior to IL-2 production, the generation of cytotoxic 
activity for the tumor target correlated with maximum IL-2 
production following seven to ten days of culture. 
Disturbances in the production of IL-2 and/or defective 
responses to IL-2 may often be the cause of lowered immune 
responsiveness {Gillis, 1983). Dowjat et al. (1985) 
demonstrated inter-strain differences in the proliferative 
response of normal spleen cells to IL-2. The differential 
response appeared to be genetically determined by multiple 
dominant or codominant genes. The genetic determinants most 
likely control differences in the composition of T 
lymphocyte populations residing in the spleen, or in the 
density of IL-2 receptors on splenocytes. The proliferative 
response of splenocytes from C57Bl/6 mice to IL-2 were among 
the highest of the strains examined (high responding 
strains), while C3H splenocytes possessed the lowest 
response to IL-2 (low responder strains) (Dowjat et al., 
1985). Differences in the kinetics of cytokine production 
were noted between the two types of responders. The 
cytokine production of low responder strains peaked prior to 
the cytokine production of high responder strains (Zhou et 
Al•i 1989b). Furthermore, high responder spleen cells 
contained two to four times more IL-2R transcript than low 
responding strains and possessed a higher frequency of IL-
2R+ cells in the spleen (Zhou et al., 1989a). 
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It is interesting to note that the IL-2 highly 
responsive strain, C57Bl/6 (Dowjat et al., 1985), was highly 
resistant tog. albicans infections (Marquis et al., 1986). 
The ability of this high responder strain to stimulate 
higher levels of cytokine production for extended lengths of 
time implies a possible role for this cytokine in the 
differential anti-fungal response. The increased levels of 
IFN gamma, TNF and IL-2 suggest a higher potential for 
activation of MHC-unrestricted populations. This increase 
may be responsible for the observed increase in survival 
following g. albicans infection in high responder strains of 
mice. 
Cytokine Induction of MHC-Unrestricted Lymphocytes in 
Response to c. albicans. 
The cell wall of g. albicans is a powerful biological 
agent, with a range of potential effects not dissimilar from 
those induced in normal PBMC by IL-2 (Vecchiarelli et al., 
1989). The microorganism is able to stimulate non-specific 
lymphocyte proliferation both in vivo and in vitro (Ausiello 
et al., 1989). g. albicans possesses the ability to 
initiate a cascade of events which allows generation of 
potent cytotoxic effectors that are active against tumor 
cell targets in vitro and in vivo (Cassone et S!.l., 1987). 
The activation of these lymphocytes is through lymphokine 
production which is induced by the c. albicans cell wall 
(Ausiello et al., 1988). 
Cassone et al., (1987) found~. albicans cell wall 
components to induce anti-YAC-1 activity of peritoneal 
effectors. At least two cell wall fractions, the 
glucomannan protein (GMP) and the insoluble glucan (GG), 
induced the appearance of peritoneal immunoeffectors (55% 
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LGL cells, 30% macrophages, and 10% PMNs) which were similar 
to those induced by the intact cells. The activity of the 
cell wall fractions did not differ in the intensity of the 
elicited effect, but rather in the kinetics of cytotoxicity 
and its duration. The cytotoxic potential generated by the 
GMP was detected as early as the activity induced by intact 
~. albicans, but lasted a shorter period of time. The 
effector response of GG peaked later than the response to 
intact ~. albicans. These findings indicate multiple 
compounds within the cell wall of ~- albicans induce anti-
tumor activity with varying effects. The immune response to 
~. albicans may be regulated by the breakdown products of 
the cell wall either through immunological degradation or 
release of cell wall components by ~. albicans (Cassone et 
al., 1987). 
studies evaluating the induction of cell-mediated 
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cytotoxicity in cultured human PBMC by GMP, have shown GMP 
induces a strong, LAK type, MHC-unrestricted cytotoxic 
response, similar to that induced with IL-2 (Ausiello et 
~., 1989). Analysis of surface phenotype coupled with 
complement-mediated depletion experiments, indicated a 
strong similarity between GMP and IL-2 activated cytotoxic 
effectors. Depletion of CD16+ (Fe receptor) and CDJ8+ (p45) 
lymphocytes substantially decreased the cytotoxic activities 
of the induced population against tumor targets (Ausiello et 
al., 1989). 
The above studies demonstrate that the cell wall of g. 
albicans is a powerful antigen-complex which has the 
capacity to serve as an immunomodulator. The in vivo 
relevance, if any, of g. albicans antigen induced activated 
lymphocytes in immune surveillance against g. albicans, 
tumors, or other microorganisms is presently unknown. The 
ability of the host to respond to infection with g. albicans 
by producing lymphocytes with MHC-unrestricted cytotoxic 
activity would indicate such a response is possible. 
IL-2 Induction of MHC-Unrestricted Lymphocytes. 
A. LAK cell phenomenon 
IL-2 is a lymphokine produced by helper T cells that 
stimulates the growth and differentiation of lymphocytes 
(Herberman and Holden, 1978). The incubation of normal 
lymphoid cells with IL-2 leads to the generation of a MHC-
unrestricted cytotoxic lymphocyte population termed 
iymphokine-activated killer (LAK) cells (Timonen et al., 
1991). several reports have shown that LAK cells are 
effective in some patients with advanced cancer when 
combined with IL-2 treatments (Richards, 1989). 
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A significant amount of literature has addressed the 
functional capabilities of this cell population. The term 
LAK has been referred to as both an activity as well as a 
cell population. No agreement upon a defined function 
associated with the term LAK has been reached. Rather, any 
function mediated by a lymphokine activated killer cell has 
been described as LAK activity. IL-2 is an inducer of LAK 
activity. However, the term lymphokine within lymphokine 
activated killer cell indicates that any cellular product of 
lymphocytes which induces this activity may result in LAK 
activity. Furthermore, the wide range of activities 
mediated by this population may not be intrinsic to the 
entire population. It has therefore been argued that LAK 
activity is a function of multiple cell populations rather 
than a single cell population mediating several functional 
activities (Reynolds and Ortaldo, 1987; Lotzova and 
Herberman, 1987). The precise relationship of these 
multiple cell types or functional activities is unknown. 
B. Characterization of LAK 
Incubation of mouse spleen cells in vitro with IL-2 
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results in the generation of a cell population capable of 
lysing a wide variety of tumor cells. IL-2 alone is fully 
capable of generating LAK activity in the absence of other 
added lymphokines (Yang et al., 1906). Other cytokines 
including TNF, IFN gamma and IL-4 also provide a degree of 
activation for LAK activity which when coupled with low 
levels of IL-2 provides a level of activity similar to that 
obtained with high doses of IL-2 alone (Blay et al., 1990). 
Lafreniere et al., (1986) have shown that IL-2 
generated murine LAK cells stimulated in vitro remain 
cytotoxic for 11 days. However, the stimulated cells failed 
to proliferate following the first cycle of expansion which 
concluded at day 8. Early studies of LAK phenotype in 
C57Bl/6 mice demonstrated the expression of ASGM-1 and Thy-
1. 2 (Merluzzi et al., 1906; Merluzzi, 1985). The majority 
of splenic LAK effectors reside in the Thy-1+, Lyt-2+ 
population (Yang et al., 1986; Mule et al., 1987). More 
recent studies have demonstrated the effector phenotype of 9 
day LAK cells to be Thy-1+, Lyt-2+, and ASGM-1+ cells. (Mule 
et al., 1989). Furthermore, it has been shown that 5-day 
IL-2 induced effectors consist of two mutually exclusive 
subsets bearing either the NK 1.1 or Lyt-2 phenotypic marker 
(Kalland et al., 1987). 
LAK Target Cell Recognition. 
A model for LAK cell binding by a variety of cell 
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surface proteins common to T cells and NK cells has been 
proposed (Thiele and Lipsky, 1989). Antibodies to 
CDlS/CDlla (LFA-1), CD2 (LFA-2) and CD45 have all been shown 
to interfere with LAK activity for tumor cells (Schmidt et 
~., 1985; Thiele and Lipsky, 1988). It has also been noted 
by a number of investigators that no single member of this 
group of cell-surface proteins can be implicated in the 
lysis of all susceptible targets by a given population of 
effector cells (Thiele and Lipsky, 1989). Thus, when LAK 
cells have been examined, lysis of some susceptible targets 
is not affected by binding of the same antibody to the same 
effector cell population (Pawelec et al., 1985; Thiele and 
Lipsky, 1988). The variability with which anti-CD45, anti-
CD2 or anti-CD18 antibodies inhibit killing, and the 
variability with which these agents interfere with 
cytotoxicity, suggests that no unique cell surface receptor 
is likely to explain the recognition and triggering of lysis 
of all susceptible targets by a population of LAK effector 
cells. When multiple effector target cell combinations have 
been examined, variation in inhibition of lysis of 
antibodies to these cell surface proteins has been found to 
be primarily dependent on the target cell employed. 
Furthermore, an inverse relationship between the degree of 
inhibition induced between antibodies to CD18/CDlla and 
antibodies to CD2 has been noted. Lysis of targets most 
resistant to inhibition by anti-CD18/CD11a are relatively 
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susceptible to inhibition by anti-CD2. The inverse is also 
true; target cells resistant to anti-CD2 inhibition are 
susceptible to inhibition by anti-CD18/CD11a (Thiele and 
Lipsky, 1988). These experiments suggest that the 
apparently promiscuous nature of target cell killing 
exhibited by LAK cells appears related to the presence of 
multiple sets of non-polymorphic receptor molecules which, 
in varying combination, can interact with all or virtually 
all, of a heterogeneous panel of tumor cell targets (Thiele 
and Lipsky, 1989). 
Evidence for the role of laminin-like molecules as 
structures involved in tumor cell recognition by LAK was 
provided by several findings. First of all, the structure 
is expressed only on lymphocytes mediating non-MHC 
restricted cytotoxicity. Secondly, affinity purified 
antibodies to laminin block target cell killing. Finally, 
anti-laminin antibodies modulate the levels of IL-2 induced 
proliferation of LAK (Schwarz and Hiserodt, 1988). The 
potential role of laminin-like molecules as receptors for 
LAK in mediating anti-tumor activity was emphasized by 
expression of a laminin matrix on tumor cells of mice, rats, 
and humans but not on normal cells. Therefore, the 
interaction with laminin may serve as a mechanism for 
recognition of cells that express altered growth or 
differentiation properties. 
1§9hanisms of cytotoxic Activity for Tumor Cells. 
Binding of tumor cell targets by effector cells is 
required for cell mediated cytotoxicity. The binding 
process can occur through any of the complex mechanisms 
previously discussed or through antibody-antigen mediated 
contact. Any process which brings these two cell 
populations together possesses the potential to permit the 
cytotoxic process. 
The mechanisms of cytotoxicity can be separated into 
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distinct steps. The first two are recognition and binding, 
followed by the post binding cytotoxic effect which leads to 
the lysis of the target cell. 
A. Recognition 
The recognition of the target cells by MHC-unrestricted 
lymphocytes is unclear. No singular receptor has been 
identified. It is presumed that LAK cells possess membrane 
structures or receptors that mediate the recognition process 
by which they distinguish targets (Edwards et al., 1989). 
Recognition of tumor cells by non-antigen specific 
lymphocytes has also been attributed to either recognition 
of precise proteins or non-specific lectin like molecules 
(Edwards et al., 1989). Glycosylated proteins, glycolipids, 
sialic acid, and amino sugars inhibit the interaction of 
tumor cells and nonspecific effectors (Axberg, 1988; Yagita 
et al., 1989). Subtle molecular changes in surface exposed 
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carbohydrates of target cells alter their sensitivity to 
lysis by nonspecific effectors (Axberg, 1988). Furthermore, 
simple sugars such as mannose block the cytotoxic activity 
of natural cytotoxic cells against solid tumors in vitro 
(Stutman et al., 1980). Several other possible target 
molecules have been proposed to explain cell recognition 
including transferrin (Alarcon and Fresno, 1985), laminin 
(Hiserodt et al., 1985), fibrinogen {Schwarz and Hiserodt, 
1988), and lectin-like recognition structures (Stutman et 
al. I 1980) • 
As discussed in a previous section, antigen-independent 
pathways of effector-target cell binding mediate the 
interaction of CD2 on effector cells and LFA-3(CD58) on 
target cells, LFA-1 (CD11a/CD18) on effector cells and ICAM-
1 (CD54) on target cells, and CD45 on effector cells (Thiele 
and Lipsky, 1989). The relative contribution of these 
pathways to cell binding is variable among combinations of 
effector and target cells. Nitta et al., (1989) have 
isolated another minor adhesive molecule on NK and LAK 
cells, CD56. However no definitive receptor has been 
isolated and a combination of receptors may provide a 
complex recognition scheme for these cells. 
B. Binding 
In order to exert their cytotoxic activity, cells must 
bind the target, undergo an activation process leading to 
release of lytic factors and, finally, establish suitable 
spatial conditions in order for these factors to reach the 
target and to exert their function (Edwards et al., 1989). 
Thus an intimate relationship between effector and target 
cell is necessary. 
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Recent evidence suggests that the target cell may 
participate actively in the mechanism leading to its own 
lysis. Results of the interaction between cells stimulated 
with low levels of IL-2 and both NK-resistant and NK-
sensiti ve tumor targets have revealed slightly different 
mechanisms of cytotoxicity. LAK and K562 interactions were 
characterized by a broad cell to cell contact whereas tumor 
cell targets susceptible only to LAK cells did not undergo 
extensive surface structure redistribution and the cell to 
cell contact was established to a lesser extent. Therefore, 
it is conceivable that the susceptibility of the target cell 
is also related to the ability of the target cell to 
redistribute its surface structures, probably through a 
rearrangement of cytoskeletal components. These changes 
might produce enhancement of the lytic effect by 
establishing the appropriate micro-environment for cytotoxic 
factors released by the effector cell (Arancia et al., 
1989). 
c. Cytotoxic granules 
A current model postulates that stored cytotoxins in 
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cytoplasmic granules are released onto target surf aces by 
ca2+-dependent degranulation after appropriate stimulation 
by the target cell (Hayes et al., 1989). These granules can 
be isolated from many killer cell types and contain, a pore-
forming cytotoxin called either perforin, cytolysin, or 
pore-forming protein (Zanovello et al., 1989). For example, 
studies by Young (1989) have shown spleen cells cultured in 
vitro in the presence of IL-2 and other T-cell growth 
factors acquire perforin-containing granules (Young, 1989). 
various molecules including TNF, serine esterases, 
proteoglycans, and lysozymes have been isolated from 
cytotoxic granules (Kamada et al., 1989). The subcellular 
location of the protease and serine esterase activity 
appears to be in the outer cytoplasmic membrane and within 
the intracellular granules (Lavie and Zucker-Franklin, 
1989). 
D. Release of granules 
A simple and attractive model to explain lymphocyte 
mediated killing has been proposed (Young, 1989). Once the 
effector cell is bound, the microtubule-organizing center 
and the Golgi apparatus to which the granules are attached, 
are repositioned to face the contact area with the target 
cell {Zanovello et al., 1989). This rearrangement serves to 
direct the cytoplasmic granules toward the contact site and 
to allow their content to be secreted by exocytosis into the 
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narrow space between effector and target cell (Arancia et 
§]..., 1989). Upon release of the granules into the directed 
space, perforin binds and polymerizes into cylinders with an 
internal diameter of 160 A. These cylinders orient in the 
plane of the target cell membrane to form pores analogous to 
the polymerized CS to C9 components of the membrane attack 
complex of the complement system. Pore formation leads to 
rapid lysis. 
An alternative model of cytotoxicity is the internal 
disintegration model in which the LAK cell induces an 
autolytic mechanism in the target. This model, originally 
proposed by Russell (1983), derives from the observation 
that target cell DNA is released from the nucleus before 
lysis and during the cytotoxic reaction. The DNA of some, 
but not all target cells undergoes fragmentation into repeat 
units of 150-180 base pairs during attack. Whether the 
endonuclease activity is directly introduced from outside or 
is endogenously activated from inside the target cell during 
the lethal event is unknown. Isolated granules have been 
demonstrated to mediate target cell DNA release (Hayes et 
al., 1989). This activity is mediated by a serine protease 
located in the secretory granules of the effector cell. 
Proteolytic enzymes (proteases and serine esterases), 
have long been implicated as having a major role in the 
lytic phase of the cytotoxicity reaction (Lavie et !!l· 
1985). Besides a role in the release of DNA from target 
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cells, proteases are involved in models of granule release. 
A variety of such enzymes are distributed within different 
compartments of the effector cell. It is clear that all 
enzymes involved in the cytotoxic response are not active at 
all times during the cytotoxic response. Furthermore, all 
enzymes are not active against all target cells with which 
they come in contact, rather a degree of selectivity exists. 
complex cellular mechanisms triggered by the binding of the 
target cell via the receptor are involved along with 
proteolysis. This may explain the selective nature of the 
lysis which is not indiscriminately active against all 
cells, but is dependent on target cell binding by the 
specific receptor followed by triggering of a specific 
cytotoxicity mechanism. Therefore upon recognition of a 
given target cell, any or all of several proteases which 
induce the cytotoxic mechanism may be activated. A model 
has been suggested by which surf ace-associated proteolytic 
enzymes that are concealed from the external environment 
during the resting phase become exposed during cytolysis and 
participate in the initial phase of target cell damage 
(Lavie et al. 1985). 
While protease inhibitors diminish cytotoxicity against 
tumor cells, they are only active during the lytic process 
(Lavie et al., 1985). Chelating agents for ca+2 but not 
Mg+2 , have been shown to block the exposure of the surface 
proteolytic enzymes (Young et al., 1986). Furthermore, 
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conjugate formation is not inhibited by addition of protease 
inhibitors. It is believed that the activity of the 
proteolytic enzymes occurs at a' stage which precedes the 
calcium-dependent effector phase but which follows the 
magnesium-dependent cell adhesion phase (Rodgers et al. 
!988). The accessibility of these proteolytic enzymes to 
inhibition declines first to large molecular weight 
inhibitors and within a few minutes to smaller molecular 
weight inhibitors. Following a ten minute incubation, 
addition of protease inhibitors fails to inhibit the 
cytotoxic response indicating the lytic process is completed 
within a concealed and localized microenviroment. 
Upon contact and recognition of a target cell, the 
effector cell initiates a series of events by which 
proteases, contained within granules, are brought to the 
effector cell surface and released into the microenviroment. 
This process mediates the cytotoxic activity of the effector 
cell (Lavie et al. 1985; Hayes et al., 1989). 
Relevance of Cytokine Activated Lymphocytes in c. albicans 
infection. 
The physiological role of cytokine activated 
lymphocytes in Q. albicans infection is at present 
uncertain. This phenomenon may be an artifact of in vitro 
activation protocols. However, cells with MHC-unrestricted 
cytotoxic activity have been shown to be present in fluids 
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isolated from inflammatory sites (Goto and Zvaifler, 1985), 
and at low frequency in the peripheral blood of normal 
individuals (Lanier et al., 1987). Therefore, the 
possibility that cytokine activated lymphocytes play a role 
in non-specific effector functions involved in host 
resistance to neoplasia or various infectious diseases, must 
be considered. Cytokine activated lymphocytes may possess 
relevant anti-g. albicans activity during the immune 
response. g. albicans possesses the ability to increase 
cytokine production in the host. The cytokines which are 
produced in response to g. albicans have been shown to 
activate MHC-unrestricted, cytotoxic lymphocytes 
(Vecchiarelli et al., 1989). Furthermore, MHC-unrestricted 
cytotoxic lymphocytes can be isolated from mice either 
inoculated with g. albicans or its cell wall constituents 
(Cassone et al., 1987; Ausiello et al., 1988). It is 
unfortunate that these investigations failed to evaluate the 
anti-g. albicans activity of these cellular populations. 
This dissertation will evaluate rIL-2 activated, 
lymphocyte-mediated, anti-g. albicans growth inhibitory 
activity, in vitro. 
The major objectives of this investigation were: 1) to 
determine whether such a population can be activated to 
mediate anti-g. albicans activity, 2) to characterize the 
cell population through phenotyping and functional activity, 
and 3) to provide a basis for assessment of IL-2 activated 
iymphocytes as a protective anti-~. albicans effector 
population. 
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MATERIALS AND METHODS 
C57Bl/6 female mice, ages 6 to 7 weeks, were obtained 
from Jackson Laboratory, Bar Harbor, ME. Experimental mice 
were 6 to 12 weeks of age when used in experiments. 
Tumor Cell Lines 
The cell line P815, a methylcholanthrene-induced 
mastocytoma in DBA/2 mice (Plaut et al., 1973) was obtained 
from the American Type Culture Collection (ATCC-TIB-64), 
Rockville, MD. YAC-1, a Moloney virus-induced lymphoma in 
A/Sn mice (Sjogren and Marbrook, 1965) was obtained from Dr. 
J. Clancy, Loyola University Medical Center, Maywood, IL. 
These tumor cell lines were used for assessment of tumor 
cytotoxic activity. Cells were maintained in suspension 
cultures in vitro in Corning 25 cm2 tissue culture flasks 
(Corning Glass Works, Corning, NY) in RPMI 1640 (Gibco 
Laboratories, Grand Island, NY) supplemented with 10% fetal 
bovine serum (FBS; low LPS; Gibco Laboratories), 100 
units/ml penicillin, 100 µg/ml streptomycin (Whittaker M. A. 
Bioproducts, Walkersville, MD), 0.1 mM non-essential amino 
acids and 2 mM 1-glutamine (Gibco Laboratories, Grand 
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Island, NY). This medium was used throughout, except where 
noted, and referred to as culture medium. 
Eungal culture 
candida albicans American Type Culture Collection 
(ATCC) 58716, was obtained from Or. T. Hashimoto, Loyola 
university Medical Center, Maywood, IL, and used throughout 
this investigation. Cultures were stored at 25°C on 
sabouraud's dextrose agar (SDA) (Becton Dickinson and Co., 
cockeysville, MD) • Cells used for experimentation were 
cultured overnight at 37°C on SDA, collected as isolated 
colonies, and washed once in Hank's balanced salts solution 
(HBSS). Cultures of yeast form with greater than 15% 
budding g. albicans were discarded. g. albicans were 
inoculated into RPM! 1640 medium prepared as described above 
except supplemented with 1% FBS not 10% FBS. This medium is 
referred to as assay medium. ~. albicans hyphal forms were 
obtained by incubation at 37°C in assay medium. Inoculum of 
l x 105 yeast cells/ml yielded approximately 100% hyphal 
fragments ranging in length from 30-50 µm when incubated for 
2 h at 37°C. 
Recombinant IL-2 
Purified recombinant human IL-2 was obtained from 
Hoffmann LaRoche, Inc., Nutley, NJ. The recombinant IL-2 
(rIL-2) was diluted to desired concentrations in culture 
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medium. 
_erotease Inhibitors 
TAME (p-a-toluenesulfonyl-L-arginine methyl ester or 
Na-p-tosyl-L-arginine), aprotinin (trasylol), and PMSF 
(phenylmethylsulfonylfuloride or p-a-toulenesulfonyl 
fluoride) were purchased from Sigma Chemical Co. (St. Louis, 
MO). TAME, a serine protease inhibitor, specific for 
arginine binding sites, was diluted to a final experimental 
concentration of lOµM. Aprotinin, a trypsin inhibitor, was 
used at a final experimental concentration of 10% of the 
initial commercial solution, and PMSF, a serine esterase 
inhibitor, was dissolved in ethyl alcohol prior to final 
experimental concentration of 300 µg/ml in RPMI 1640. 
Addition of these reagents to target cells showed no 
alteration in [3H] uridine uptake by these cells compared to 
untreated ~. albicans. The reagents did not affect effector 
cell viability as judged by trypan blue exclusion. 
IL-2 Activation of Lymphocytes 
Spleens from untreated mice were aseptically removed. 
Single cell suspensions were prepared by dissociating the 
spleen through a 60-gauge wire mesh with the hub of a 
syringe. Spleen cells were washed once in HBSS prior to 
placement in culture medium containing 5 X 10~ M 2-
mercaptoethanol (2-ME) at a concentration of 2.5 x 106 
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cells/ml with 1500 U/ml rIL-2 in Falcon, Multiwell plates 
(Becton Dickinson and Co., Oxnard, CA). The cells were 
harvested following incubation at 37°C, overlaid onto 
Lymphocyte Separation Medium (Litton Bionetics, Kensington, 
MD) and centrifuged at 1000 X g for 20 min. The cells at 
the interface were washed twice with HBSS prior to 
assessment of cytocidal or growth inhibitory activity. 
Percoll Separations 
Freshly isolated splenocytes, harvested as above, were 
subjected to discontinuous Percoll gradients consisting of 
50 to 70% Percoll (Sigma Chemical, St. Louis, MO) at 1500 x 
g for 30 min. Each cell fraction was collected, washed 
twice in HBSS and resuspended in assay media prior to 
experimentation. Day 7 cell fractions were designated as 
fraction 1, representing the population banding above the 
50% gradient; fraction 2, representing the population 
banding between the 50% and the 60% gradient; and fraction 
3, representing the population banding below the 60% 
gradient. 
Supernate Collection 
Day 7 cultured cells were harvested by centrifugation, 
and separated from culture medium. Following separation, 
culture media from normal cells as well as from those co-
cultured with~. albicans at 25:1 effector : target ratios 
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were concentrated 75 fold with a Diaflo ultrafiltration 
membrane (Amicon Corp., Danvers, MA) concentration device 
with a UMlO filter. 12 to 200 µl of concentrated supernate 
were analyzed for inhibitory and cytotoxic activity. 
preparation of Cell Sonicates 
Effector populations were resuspended in polypropelene 
12 x 75 mm tubes at 5 x 106 cells/ml in 1 ml. Populations 
were subjected to sonication by the Fisher Sonic 
oismembrator Model 300 (Farmingdale, NY) at 35% capacity for 
15 seconds while on ice. Sonicated cells were < 1% viable 
as judged by trypan blue exclusion. Preparations of 
sonicates including membranes and cytosols were treated as 
equivalent cell populations at 5 x 106 /ml for analysis of 
inhibitory or cytotoxic activity. 
Kinetic Analysis of Cell Recovery and Proliferation 
Freshly isolated spleen cells (collected as above) were 
cultured in culture media and harvested (as above) 
sequentially from day 1 to day 9 of culture. The total 
number of recoverable cells divided by the original number 
of cells placed in culture, multiplied by 100 was the 
percent recovery. Lymphoid cells were plated in 96 well 
flat-bottomed microtiter plates (Corning 25861, Corning, NY) 
at 5 x 105 cells/well. Cells were cultured with or without 
300 u/well of rIL-2. Cells were cultured from 1 to 9 days 
after which they were pulsed with 1 µCi/well of [3H] 
thymidine (ICN Radiochemicals, Irvine, CA). After 6 h of 
incubation, cells were harvested on the PhD harvester 
(Cambridge Technology, Cambridge, MA) and associate 
radioactivity determined with a Beckman LS5801 ~ liquid 
scintillation counter (Irving, CA). Proliferation was 
defined as the incorporation of [3H] thymidine in the 
experimental wells containing rIL-2 (300 U/ml) divided by 
the incorporation of [3H] thymidine in the control wells 
without rIL-2. 
Flow cytometric Analysis 
43 
Antibodies used to analyze the phenotype of cell 
populations included monoclonal rat anti-mouse Lyt 2.2 
(clone 53-6.7; biotin conjugated), monoclonal rat anti-mouse 
Thy 1.2 (clone 30Hl2; biotin-conjugated) and monoclonal rat 
anti-mouse L3T4 (clone GK 1.5; phycoerythrin-conjugated), 
all from Becton-Dickinson (Mountain View, CA). Monoclonal 
anti-NK 1.1 (clone PK136; mouse IgG) was obtained from ATCC 
(Rockville, MD). Rabbit anti-Asialo GM-1 (ASGM-1) was 
obtained from Wako Chemicals USA, Inc. (Dallas, TX), and was 
used with goat anti-rabbit Ig fluorescein conjugate 
(Boehringer Mannheim Biochemicals; Indianapolis, IN). 
Fluorescein conjugated goat anti-mouse IgG from Zymed 
Laboratories Inc. (South San Francisco, CA) was utilized to 
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detect surface IgG. Streptavidin-phycoerythrin was obtained 
from vector Laboratories (Burlingame, CA). Effector 
populations were prepared for phenotyping by washing 1.5 x 
106 cells per sample once with cold phosphate buffered 
saline (PBS). The cells were incubated with the primary 
antibody for 30 min. on ice. Following two washes in cold 
PBS, the cells were incubated for an additional 30 min. on 
ice with secondary antibody, protected from light. Control 
samples consisted of cells incubated only with the secondary 
antibodies. The cells were washed twice in cold PBS, and 
then fixed with 0.1 ml of 1% paraformaldehyde in saline and 
stored at 4°C. The samples were washed twice and 
resuspended in PBS prior to flow cytometric analysis (FACS 
Analyzer ISA, Becton-Dickenson, Mountain View, CA). 
Complement-Mediated Depletion Analysis 
Antibodies used to deplete cell populations included 
monoclonal anti-Lyt 2.2 (clone AD4(15); mouse IgM) from 
Accurate Chemical and Scientific Corp. (Westbury, NY), anti-
Thy-1 from Hybritech Inc. (San Diego, CA), monoclonal anti-
NK 1.1 (clone PK136; mouse IgG) obtained from ATCC 
(Rockville, MD), and rabbit anti-ASGM-1 obtained from Wako 
Chemicals USA, Inc. (Dallas, TX). Viable lymphoid cells 
were obtained with a Lymphocyte Separation Medium gradient 
as above and washed twice with HBSS. Effector populations 
were depleted of cells bearing specific antibodies by 
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incubating 1 x 107 cells with saturating levels of antibody 
for 1 h at 4°C. The cells were washed 3 times with HBSS 
with 1% FBS to remove excess antibody and then 100 µl of Low 
ToX M rabbit complement (Accurate Chemical and Scientific 
corp., Westbury, NY) was added to the cell pellet. 
Following a 1 h of incubation at 37°C, cells were washed, 
obtained with a Lymphocyte Separation Medium gradient as 
above, and washed twice prior to assessment of inhibitory or 
cytotoxic activity. Effectiveness of the depletion was 
assessed by flow cytometric analysis and number of recovered 
cells from treated populations compared to untreated 
populations. 
Immunomagnetic selection 
Antibodies used for immunomagnetic selection included 
monoclonal anti-Lyt 2.2 (clone 19/178; mouse IgG) obtained 
from Dr. Erlich Hammerling, Sloan-Kettering Institute New 
York, NY, monoclonal anti-NK 1.1 (clone PK136; mouse IgG) 
obtained from ATCC (Rockville, MD), and magnetic goat anti-
mouse IgG obtained from Advanced Magnetics (Cambridge, MA). 
Viable lymphoid cells were obtained with a Lymphocyte 
Separation Medium as above and washed twice with HBSS. 1 x 
107 day 7 cells were treated with saturating levels of 
antibody for 1 h at 4°C. The cells were washed 3 times with 
HBSS with 1% FBS to remove excess antibody and then 1 ml of 
magnetic antibody was added to the cell pellet. Following 1 
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h of incubation at 4°C, antibody sensitized populations were 
removed with a magnet. Separated populations were activated 
with 1500 U/ml rIL-2 18 h at 37°C, 5% C02 • Effector 
populations were washed, centrifuged over a Lymphocyte 
separation Medium gradient as above, and washed twice prior 
to assessment of inhibitory or cytotoxic activity. 
Tumor Cell Cytotoxicity Assay 
Tumor cells maintained in vitro were washed once in 
culture medium, pelleted by centrifugation at 500 x g for 10 
min and resuspended in approximately 0.1 ml of culture 
medium. 100 µCi of [ 51Cr] chromate (New England Nuclear, 
Boston, MA) was added to 1 x 107 cells in a final volume of 
0.2 ml. The cells were incubated at 37°C with 5% co2 for 1 h 
with agitation every 10 min. The cells were washed 4 times 
in HBSS, resuspended to 5 x 105 cells/ml in culture medium 
and 0.01 ml (5 x 103 cells) were aliquoted to each well of a 
96 well, round bottom assay plate (Corning Glass Works, 
Corning, NY). Radiolabelled YAC-1 or P815 cells were 
cultured for 4 h with lymphoid cells. Following 4 h of 
incubation, the supernates were removed using a Skatron 
harvesting press (Skatron Inc., Sterling, VA) and associated 
radioactivity determined with a 4/600 ME PLUS automatic 
gamma counter. Maximum release of radioactivity was 
obtained by adding 0.05% Nonident P-40 (Sigma Chemical 
Co., St. Louis, MO). Results are expressed as% 
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cytotoxicity as calculated by the formula: % cytotoxicity = 
{[(experimental DPM) - (minimum DPM)] / ((maximum DPM) - ( 
minimum DPM)]} x 100. All experimental means were 
calculated from triplicate values. Lytic units (LU), were 
calculated by the method of Pross et al. (1981), and 
represent the number of effector cells per 1 x 107 effectors 
required to achieve 20% lysis of the target. Lytic units 
were calculated by a program written by David Coggins (NCI, 
Fredrick, MD). 
c. albicans Inhibition 
Fungal cells used for experimentation were collected 
from isolated, overnight SDA colonies, and washed once in 
HBSS. Yeast form cells were resuspended to 2 x 105 / ml in 
assay media. 1 x 104 cells were then added to individual 
wells of 96 well plates (Corning 25861, corning, NY). g. 
albicans hyphal forms were obtained by incubation at 37°C in 
5% C02 for 2 h. Various numbers of effector cells were 
added at ratios of 50:1 to 6:1. After 3 h incubation at 
37°C in 5% co2 , effector cells were lysed and removed by 
washing with water using a PhD cell harvester (Cambridge 
Technology, Cambridge, MA). 0.05 ml of RPMI 1640 with 1% 
FBS and 1 µCi per well of [3H] uridine (ICN Radiochemicals, 
Irvine, CA) was added to individual wells. Following 1 h 
incubation at 37°C, 5%C02 , 25 U lyticase (Sigma Chemical, St. 
Louis, MO) in 50 µl HBSS was added to individual wells for 
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0 •5 h at 25°C. Cells were then harvested with a PhD 
harvester and associated radioactivity etermined with a 
seckman LS5801 ~ liquid scintillation counter. Growth 
Inhibition of~. albicans = {[(DPM ~. albicans control) -
(DPM (effector and~. albicans - effector control))] / [DPM 
~· glbicans control]} x 100. All cultures were prepared at 
least in triplicate and the mean inhibition of those values 
determined. Inhibitory units (IU), a modification of the 
lytic unit method of Pross et al. (1981), were calculated as 
the number of effector cells per 1 x 107 effectors required 
to achieve 20% inhibition of the target. Inhibitory units 
were calculated as DPM ~. albicans alone - DPM experimental 
sample = inhibited counts. Inhibited counts were determined 
by a modification of a program written by David Coggins 
(NCI, Frederick, MD) and presented as inhibitory units. 
Cold target Inhibition 
Tumor cytotoxicity and ~. albicans inhibitory assays 
were conducted at 40:1 effector : target ratio. 
Additionally, cultured tumor targets (P815 and YAC-1) and 
heat inactivated (5 minutes at 100°C) ~- albicans hyphae 
were utilized as cold targets. Cold target inhibitors were 
washed twice in HBSS prior to co-incubation with effector 
and target cells at concentrations from 1 x 104 to 5 x 106 
additional cold targets per well. Naive thymocytes were 
utilized as unrelated control cell populations. Thymocytes 
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were added to each well such that the final concentration of 
cold targets and thymocytes of each well totalled 5 x 106 
cells per well. Tumor culture supernates were collected 
both from overnight and 3 day tissue culture flasks as well 
as from cultures of 5 x 106 cells in 0.1 ml from a 96 well 
plate following a 4 h culture period. ~- albicans 
supernates were collected following heat inactivation. The 
supernates were assessed for inhibition of cytotoxicity and 
~· albicans inhibition. 
statistics 
Comparisons of mean LU and IU values were performed 
using the t test for small-samples concerning difference 
between two means (Freund, 1979). 
RESULTS 
A,9tivation of Anti-fungal and Anti-tumor Activity of 
splenocytes with rIL-2 
A. Anti-fungal and anti-tumor activity of splenocytes 
The purpose of initial experiments was to determine the 
inherent anti-fungal and anti-tumor activity of murine 
splenocytes. Splenocytes possessed no growth inhibitory 
activity against ~. albicans as judged by inhibition of [3H] 
uridine uptake (Figure lA). Neither was there activity 
against the NK-resistant cell line, P815, as judged by [51Cr] 
release (Figure lC). Low levels of activity were observed 
for the NK sensitive target, YAC-1, as judged by [51Cr] 
release (Figure lB). This activity could be enriched by 
discontinuous Percoll density gradient selection. 
Splenocytes from interface 1 (cells which did not enter a 
50% concentration of Percell) showed enhanced activity 
against the YAC-1 tumor cell line when compared to 
unfractionated splenocytes (p<0.05) (Figure 2B). 
Unfractionated splenocytes possessed 5.2% large granular 
lymphocytes compared to splenocytes from interface 1 which 
possessed 38.3% large granular lymphocytes as judged by 
Wright-Geimsa staining of cytospin preparations. No 
50 
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Figure 1. 
c. albicans growth inhibition and tumor cell cytotoxicity of 
day o splenocytes. A. ~. albicans growth inhibition was 
assessed by the incorporation of [3H] uridine. Data are 
presented as % inhibition and inhibitory units per 107 cells 
at 20% inhibition (IU). B. YAC-1 cytotoxicity is expressed 
as % cytotoxicity as judged by [ 51Cr] release and by lytic 
units per 107 cells at 20% cytotoxicity (LU). c. P815 
cr.totoxicity is expressed as % cytotoxicity as judged by 
[ 1Cr] release and by lytic units per 107 cells at 20% 
cytotoxicity (LU). Data are expressed as the mean± s. D. 
for 3 independent experiments. 
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Figure 2. 
c. albicans growth inhibition and tumor cell cytotoxicity of 
percoll fractionated day o splenocytes. Day O splenocytes 
were fractionated by discontinuous percoll density gradient 
separation. Cells from each interface were harvested and 
washed: Fraction 1, 50% gradient (Fract. 1); fraction 2, 60% 
gradient (Fract. 2); and fraction 3, 70% gradient (Fract. 
3). A. g. albicans growth inhibition was assessed by the 
incorporation of [3H] uridine. Data are presented as % 
inhibition and inhibitory units per 107 cells at 20% inhibi-
tion (IU). B. YAC-1 cytotoxicity is expressed as% 
cytotoxicity as judged by [51Cr] release and by lytic units 
per 107 cells at 20% cytotoxicity (LU). c. P815 
cxtotoxicity is expressed as % cytotoxicity as judged by 
[ 1Cr] release and by lytic units per 107 cells at 20% 
cytotoxicity (LU). *, (p<0.05) Significant difference 
between fraction 1 activity and unfractionated splenocyte 
activity. Non-significant comparisons are not labelled, all 
significant comparisons are labelled. Data are expressed as 
the mean ± s. D. for 3 independent experiments. 
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increase in anti-YAC-1 tumor cell activity was noted for the 
other Percell separated splenocytes. No enrichment of 
activity was noted for any of the other Percell separated 
cell populations against either g. albicans (Figure 2A) or 
P815 (Figure 2C) . 
These data demonstrate no anti-g. albicans or anti-P815 
activity in either splenocytes or Percell separated 
populations at the effector to target ratios used in these 
experiments. The anti-YAC-1 activity of normal splenocytes 
was enhanced in low density Percell fractions, suggesting 
that resident splenic NK do not mediate anti-g. albicans 
activity. 
B. Activation of anti-fungal and anti-tumor activity in 
splenocytes with rIL-2 
Previous studies have shown that activation of lymph 
node cells by rIL-2 augments their anti-fungal activity 
(Beno and Mathews, 1990) and anti-tumor activity (Herberman 
and Holden, 1978). To evaluate the effect of this cytokine 
on splenocytes, such cell populations were activated with 
rIL-2 and assayed for their capacity to mediate anti-g. 
albicans and anti-tumor activities (Figure 3). 
Following 1 day activation by rIL-2, no increase in 
either g. albicans growth inhibition (Figure 3A) or anti-
P815 cytotoxic activity (Figure JC) was noted for these 
splenocytes when compared to the activity of day o 
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splenocytes or splenocytes cultured for 1 day without rIL-2 
(unactivated) (p>0.05). However, the increase in anti-YAC-1 
cytotoxic activity (Figure JB) was significant when compared 
to day o splenocytes or unactivated day 1 splenocytes 
(p<0.05). Following 3 days activation with rIL-2, c. 
albicans growth inhibition (Figure 4A) was increased 
significantly when compared to day o splenocyte activity or 
the activity of splenocytes cultured for 3 days without rIL-
2 (unactivated day 3) (p<0.05). Anti-P815 cytotoxic 
activity of splenocytes (Figure 4C) was increased 
significantly at day 3 of culture (p<0.05). Splenocytes 
cultured without rIL-2 showed no (p>0.05) anti-P815 
activity. Anti-YAC-1 activity (Figure 4B) was enhanced 
significantly from day O to day 3 of incubation with rIL-2 
(p<0.05). No change in anti-YAC-1 activity was observed for 
splenocytes cultured 3 days without rIL-2 (p>0.05) when 
compared to day O splenocytes. Following activation with 
rIL-2 for 7 days, ~. albicans growth inhibition and anti-
tumor cytotoxic activity was increased significantly over 
day o splenocytes (p<0.05) (Figure 5). No cells were 
recovered from splenocytes cultured without rIL-2 for more 
than 3 days. The ~. albicans growth inhibitory activity of 
splenocytes cultured for 7 days with rIL-2 was increased 
significantly (p<0.05) when compared to 3 day activated 
splenocyte populations for all targets examined (Figures 4 
and 5). Day O splenocyte activity against all targets 
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Figure 3. 
c. albicans growth inhibition and tumor cell cytotoxicity of 
day 1 rIL-2 activated populations. A. ~. albicans growth 
inhibition was assessed by the incorporation of [3H] 
uridine. Data are presented as % inhibition and inhibitory 
units per 107 cells at 20% inhibition (IU). B. YAC-1 
critotoxicity is expressed as % cytotoxicity as judged by 
[ 1Cr] release and by lytic units per 107 cells at 20% 
cytotoxicity (LU). c. P815 cytotoxicity is expressed as% 
cytotoxicity as judged by [51Cr] release and by lytic units 
per 107 cells at 20% cytotoxicity (LU). *, (p<0.05) 
Significant difference between activity of day 1 rIL-2 
activated population compared to day o splenocyte activity. 
**, (p<0.05) Significant difference between activity of day 
1 rIL-2 activated populations compared to the activity of 
day 1 cultured without rIL-2. Data are expressed as the 
mean ± s. D. for 4 individual experiments. 
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Figure 4. 
c. albicans growth inhibition and tumor cell cytotoxicity of 
day 3 rIL-2 activated populations. A. ~. albicans growth 
inhibition was assessed by the incorporation of [ 3H] 
uridine. Data are presented as % inhibition and inhibitory 
units per 107 cells at 20% inhibition (IU). B. YAC-1 
critotoxicity is expressed as % cytotoxicity as judged by 
[ 1cr] release and by lytic units per 107 cells at 20% 
cytotoxicity (LU). C. P815 cytotoxicity is expressed as% 
cytotoxicity as judged by [ 51Cr] release and by lytic units 
per 107 cells at 20% cytotoxicity (LU). *, (p<0.05) 
Significant difference between activity of day 3 rIL-2 ac-
tivated population compared to day o splenocyte activity. 
**, (p<0.05) significant difference between activity of 
either day 3 rIL-2 activated populations compared to the 
activity of day 3 splenocytes cultured without rIL-2. Data 
are expressed as the mean + s. D. for 4 individual experi-
ments. 
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Figure 5. 
~. albicans growth inhibition and tumor cell cytotoxicity of 
day 7 rIL-2 activated populations. A. ~. albicans growth 
inhibition was assessed by the incorporation of [ 3H] 
uridine. Data are presented as % inhibition and inhibitory 
units per 107 cells at 20% inhibition (IU). B. YAC-1 
critotoxicity is expressed as % cytotoxicity as judged by 
[ 1Cr] release and by lytic units per 107 cells at 20% 
cytotoxicity (LU). c. P815 cytotoxicity is expressed as% 
cytotoxicity as judged by [51Cr] release and by lytic units 
per 107 cells at 20% cytotoxicity (LU). *, (p<0.05) 
Significant difference between activity of day 7 rIL-2 ac-
tivated population compared to day o splenocyte activity. 
Data are expressed as the mean ± s. D. for 4 individual 
experiments. 
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displayed in Figures 3, 4, and 5 are taken from Figure 1 and 
used to demonstrate comparative activities. The activity of 
daY o splenocytes was compared twice in parallel with the 
previous studies of rIL-2 activated lymphocytes at days 1, 
3, and 7. No differences in activity were observed between 
these cell populations and the day o splenocytes presented 
above. 
These data demonstrate a concurrent increase over time 
in anti-fungal and anti-tumor activities when splenocytes 
were cultured with rIL-2 at days 1, 3, and 7. Furthermore, 
despite the presence of enhanced NK activity at day 1, no 
anti-fungal activity was observed suggesting NK do not 
mediate anti-g. albicans activity. The induction of anti-
P815 activity at days 3 and 7 does correllate with the 
ability of the population to mediate anti-g. albicans 
activity. These results suggest activation to P815 tumor 
cytotoxic activity is associated with cell population 
activation to anti-fungal activity. 
c. Kinetic analysis of lymphoproliferation, cell recovery, 
anti-fungal activity, and anti-tumor activity of 
splenocytes following activation with rIL-2. 
To establish the time course for maximal functional 
activity as well as maximal cell recovery, splenocyte 
populations were analyzed for anti-tumor lytic activity, 
anti-g. albicans growth inhibitory activity, cell recovery, 
and lymphoproliferation during 9 consecutive days of 
activation with rIL-2 (1500 U/ml). 
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In separate experiments from those described in Figures 
l-5, splenocytes acquired anti-tumor activity against both 
YAC-1 and P815 cell lines with peak activity occurring at 
day 7 of culture with 1500 U/ml rIL-2 (Figure 6). A 
significant increase in anti-YAC-1 activity was noted as 
early as day 1 when compared to day O splenocytes (p<0.05). 
Anti-P815 activity was not significantly increased over the 
day O splenocyte population until day 3 in culture and 
demonstrated peak activity at day 7 (p<0.05). ~. albicans 
growth inhibition peaked at day 7 of culture with 
significant growth inhibition appearing by day 3 when 
compared to the activity of day o splenocytes (p<0.05). The 
activity against all targets increased until day 7 at which 
time the activity against all targets declined numerically, 
but not significantly from day 7 (p>0.05) (Figure 6). 
Maximal cell recovery coincided with maximal anti-fungal 
activity, on day 7 (Figures 6 and 7). Maximal proliferation 
of splenocytes was on day 4 of activation, 3 days prior to 
maximal cell recovery (Figure 7). Splenocytes cultured 
without rIL-2 showed no proliferative capacity and cell 
viability decreased from 75.3% ± 8.0% at day 1 to 8.8% + 
9.2% by day 3 of culture. Without rIL-2 no viable 
lymphocytes were recoverable after 3 days in culture. 
These data expand on previous experiments within this 
65 
Figure 6. 
Kinetic analysis of anti-tumor and anti-~. albicans activity 
of splenocyte populations activated with rIL-2. Splenocyte 
populations were cultured for O to 9 days with 1500 U/ml 
rIL-2 and assessed at daily intervals for anti-tumor 
activity against YAC-1 and P815 and anti-~. albicans 
inhibitory activity. ~· albicans growth inhibition was 
assessed by the incorporation of [ 3H] uridine. Data are 
presented as inhibitory units per 107 cells at 20% 
inhibition (IU). YAC-1 and P815 cytotoxicity is expressed 
as lytic units per 107 cells at 20% cytotoxicity (LU) as 
judged by [ 51Cr] release. Data are expressed as the mean ± 
s. D. for 3 independent experiments. 
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Figure 7. 
Kinetics of proliferation and cell recovery from cultures of 
rIL-2 activated populations. Splenocyte populations were 
assessed for proliferation following culture with 1500 U/ml 
rIL-2 at the days indicated. The percent of recovered cells 
during the activation with rIL-2 is also expressed. Data 
are expressed as the mean ± s. o. for 3 independent experi-
ments. 
100 150 
T 125 x 
LaJ 
80 ~'---2--6 c 100 z 
-l z <1 
>-
~I 
Q! 
60 
75 
wo 
81 
0::: <1 LaJ 
La.. 
50 -
wo 
...J 
0::: 
"'° ~ 
0 
Q! 
a.. 
25 20 
0 0 
0 1 2 3 4 5 6 7 8 10 
DAYS 
(IN CULTURE) 
Figure 7. 
O'I 
o:> 
study to demonstrate maximal anti-tumor activity, anti-
fungal activity, and cell recoverability occur at day 7 of 
culture with rIL-2. Due to these observations, the day 7 
rIL-2 activated population was selected for further 
characterization. 
susceptibility of Various Strains of Candida to rIL-2 
activated population 
69 
To examine if the anti-fungal effect of the splenocyte 
population was limited to Q. albicans strain (ATCC #58716) 
utilized in this study, various clinical isolates of Q. 
albicans and species of Candida were evaluated for their 
susceptibility to this form of lymphocyte mediated growth 
inhibition. 
Figure 8 depicts the growth inhibitory effect of the 
rIL-2 activated population on various clinical isolates of 
Candida albicans, Candida tropicalis, Candida parapsilosis, 
or Torulopsis glabrata. All isolates of Q. albicans and 
species of Candida evaluated were susceptible to growth 
inhibition by rIL-2 activated populations, indicating the 
anti-Q. albicans activity observed by the rIL-2 activated 
population is not limited to the strain of Q. albicans 
utilized in this study. 
Characterization of rIL-2 Activated Populations 
A. Flow cytometric analysis of rIL-2 activated populations 
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Figure 8. 
Growth inhibition of rIL-2 activated populations for various 
Candida strains and species. rIL-2 activated populations 
were assessed for g. albicans growth inhibition against 
clinically isolated strains of g. albicans by the uridine 
method and presented as % inhibition and IU. rIL-2 
activated populations were also assessed for growth 
inhibition against clinically isolated species of Candida. 
g. albicans and Candida species growth inhibition was 
assessed by the incorporation of [3H] uridine and data 
presented as % inhibition and inhibitory units per 107 cells 
at 20% inhibition (IU). *, indicates ATCC 58716 strain of 
g. albicans utilized throughout study. Data are expressed 
as the mean ± S. D. for 3 independent experiments. 
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In order to determine the phenotypic nature of rIL-2 
activated populations and that of day O splenocytes, both 
populations were assessed for the expression of the 
phenotypic markers; ASGM-1, NK 1.1, Ig, Thy-1.2, L3T4, and 
Lyt-2.2. 
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Four experiments comparing phenotypic expression of day 
0 splenocytes to rIL-2 activated populations are summarized 
in Table I. 52.7 ± 7.6% of day o splenocytes expressed Thy-
1.2 and 40.9 ± 4.3% expressed ASGM-1. 19.7 ± 3.3% of the 
day O splenocyte population expressed the Lyt-2.2 T cell 
marker while 10.7 ± 2.7% expressed the NK 1.1 marker. The 
number of rIL-2 activated cells expressing Thy-1.2 increased 
to 92.0 ± 3.8% and while the number of rIL-2 activated cells 
expressing ASGM-1 increased to 85.7 ± 9.6% after 7 days in 
culture with rIL-2. 53.3 ± 8.3% of the rIL-2 activated 
population expressed the Lyt-2.2 T cell marker while 36.8 + 
6.1% expressed the NK 1.1 marker. The presence of Ig and 
L3T4 phenotypic markers were also examined for rIL-2 
activated populations and day o splenocytes. Expression of 
both phenotypic markers decreased during time in culture. 
Ig expression decreased from 48.7 + 6.3 to 4.3 ± 3.7% and 
L3T4 expression decreased from 30.1 ± 4.0 to 6.0% ± 3.2%. 
These data indicate that following 7 days activation 
with rIL-2, a high percentage of lymphocytes express the 
markers Thy-1.2 and ASGM-1 while the percentage of cells 
expressing the markers NK 1.1 and Lyt-2.2 is intermediate 
Table I. Surface phenotype of day O splenocytes or day 7 
rIL-2 activated population. 
Phenotypic 
Marker Day 0 Day 7 
% Expressing8 % Expressing 
Thy-1.2 
L3T4 
52.7 + 7. 6b 92.0 ± 
30.1 + 4.0 6.0 
LYT-2.2 19.7 ± 3.3 53.3 
ASGM-1 40.9 ± 4.3 85.7 
NK 1.1 10.7 ± 2.7 36.8 
Ig 48.7 ± 6.3 4.3 
FITC-RAMigc 7.8 + 2.2 8.5 
PE-avidind 8.9 + 3.1 8.7 
FITC-GAMige 6.3 + 4.4 4.6 
a As judged by flow cytometric immunofluorescence. 
b Mean + s. D. of 4 independent experiments. 
c Secondary antibody for ASGM-1 (rabbit Ig). 
d Secondary marker for Thy-1.2, Lyt-2.2. 
e Secondary antibody for NK 1.1 (goat Ig). 
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3.1 
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~ithin the population. 
B. Phenotypic expression of NK 1.1 and Lyt-2.2 
To determine whether the phenotypic markers Lyt-2.2 and 
NK 1.1 are expressed on the same population with the rIL-2 
activated population, antibody and complement depletion 
experiments were performed, followed by flow cytometric 
analysis. 
Flow cytometric analysis of rIL-2 activated populations 
treated with anti-Lyt-2.2 and complement show a decrease in 
cells staining for Lyt-2.2 from 48% to 13% (Figure 9) in a 
representative experiment. In contrast, the rIL-2 activated 
population treated with anti-Lyt-2.2 and complement 
displayed increased expression of NK 1.1 from 35% to 59%. 
The rIL-2 activated population treated with anti-NK 1.1 and 
complement showed a decrease in cells staining for 
expression of NK 1.1 (35% expression in untreated 
populations compared to 11% expression of NK 1.1 in treated 
populations) yet displayed an increase in expression of Lyt-
2. 2 from 48% to 59%. Evaluation of flow cytometric analysis 
utilizing this method is limited. Special considerations 
for the use of flow cytometric analysis must be made 
following the isolation of cell subpopulations using 
antibody and complement. Similar, if not identical antibody 
binding sites may be measured for immunofluorescence as well 
as for complement mediated depletions. Therefore, residual 
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Figure 9. 
Flow cytometric histograms representing rIL-2 activated 
population following in vitro antibody and complement deple-
tions. rIL-2 activated populations were treated with anti-
Lyt-2. 2 or anti-NK 1.1, and complement; or complement alone. 
Cells were then assessed for expression of Lyt-2.2 and NK 
1.1 phenotypic markers. The left column shows rIL-2 
activated populations stained with anti-Lyt-2.2 and the 
right column shows rIL-2 activated populations stained with 
anti-NK 1.1. The first row shows complement treated rIL-2 
activated populations, the middle row rIL-2 activated 
populations treated with anti-Lyt-2.2 and complement, and 
the third row shows rIL-2 activated populations treated with 
anti-NK 1.1 and complement. Data are representative of 3 
independent experiments. 
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antibody to the cell population may block antigen expression 
as determined by flow cytometric analysis. Flow cytometric 
analysis was supported with analysis of percentage 
recoverable cells following antibody and complement 
depletions. The percentage of rIL-2 activated populations 
not expressing Lyt-2.2 as judged by flow cytometric analysis 
was 46.7 ± 8.3%. Following Lyt-2.2 antibody and complement 
treatment, the percentage of recoverable cells was 47.3 ± 
5.9% in 3 separate experiments. The decrease in the percent 
recoverable cells following anti-Lyt-2.2 and complement 
treatment to a level near the original percentage of cells 
not expressing Lyt-2.2 indicates that antibody and 
complement removed nearly all cells expressing Lyt-2.2. 
Likewise, the percent of recoverable cells following NK 1.1 
antibody and complement treatment was 74.7 ± 7.4%, 
approximately equal to the percentage of cells not 
expressing the marker {63.2 ± 6.1%) (Tables I and II). 
These data are consistent with the expression of Lyt-
2. 2 and NK 1.1 on separate cellular subsets within the rIL-2 
activated population. 
c. Functional role of Lyt-2.2 and NK 1.1 depleted 
populations 
The role of Lyt 2.2+ and NK 1.1+ cell populations in 
anti-fungal and anti-tumor cytotoxic activity was assessed 
following antibody and complement depletions of rIL-2 
Table II. Percent recovery of rIL-2 activated population 
following treatment with antibody and complement. 
Effector 
Population % Recovery 
Untreated 100.0 ± 3. 6. 
Complement 89.0 ± 6.1 
anti-Lyt-2.2 + 47.3 ± 5.9 
Complement 
anti-NK 1.1 + 74.7 ± 7.4 
Complement 
•Mean ± s. D. of 3 independent experiments. 
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activated populations. 
Populations depleted of Lyt-2.2 displayed significantly 
iower activity against both g. albicans and P815 when 
compared to rIL-2 activated populations or complement 
treated controls (p<0.05) (Figure 10). In contrast, NK 1.1 
depleted populations showed no difference in anti-fungal and 
anti-P815 activity when compared to either complement 
treated rIL-2 activated populations or untreated rIL-2 
activated population. The activity of the NK 1.1 depleted 
population against the YAC-1 cell line was significantly 
reduced {p<0.05) yet still retained activity. No difference 
in activity against YAC-1 was observed between the anti-Lyt-
2. 2 treated population and either complement treated rIL-2 
activated populations or untreated rIL-2 activated 
populations (p>0.05). 
D. Functional activity of NK 1.1+ and Lyt-2.2+ selected 
populations 
To confirm the experiments described above, Lyt-2.2+ or 
NK 1.1+ populations were selected by immunomagnetic beads 
and specific antibody 18 h prior to the assessment of anti-
fungal and anti-tumor activity. 
Against both g. albicans and P815, NK 1.1 selected 
cells (NK 1.1+ cells) and Lyt-2.2 unselected cells (Lyt-2.2· 
cells) displayed significantly reduced tumor cytotoxic and 
g. albicans growth inhibitory activity when compared to rIL-
80 
Figure 10. 
Fungal growth inhibition and tumor cell cytotoxicity of rIL-
2 activated population after in vitro antibody and 
complement depletions. rIL-2 activated populations were 
treated with complement plus anti-Lyt-2.2 or anti-NK 1.1 
complement alone, or untreated. A. ~. albicans growth 
inhibition was assessed by the incorporation of [3H] 
uridine. Data are presented as % inhibition and inhibitory 
units per 107 cells at 20% inhibition (IU). B. YAC-1 
critotoxicity is expressed as % cytotoxicity as judged by 
[ 1Cr] release and by lytic units per 107 cells at 20% 
cytotoxicity (LU). c. P815 cytotoxicity is expressed as% 
cytotoxicity as judged by [51Cr] release and by lytic units 
per 107 cells at 20% cytotoxicity (LU). *, (p<0.05) 
Significant difference between activity of Lyt-2.2 antibody 
and complement treated rIL-2 activated populations compared 
to activity of untreated, complement treated, NK 1.1 
antibody and complement treated rIL-2 activated populations; 
**, (p<0.05) Significant difference between activity of NK 
1.1 antibody and complement treated rIL-2 activated 
populations to activity of untreated, complement treated, or 
Lyt-2.2 antibody and complement treated rIL-2 activated 
populations. Data are expressed as the mean ± s. D. of 3 
independent experiments. 
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Figure 11. 
Fungal growth inhibition and tumor cell cytotoxicity of rIL-
2 activated population after in vitro selection with immuno-
magnetic beads and specific antibody. rIL-2 activated 
populations were selected with anti-Lyt-2.2 or anti-NK 1.1 
and immunomagnetic beads, or unselected populations which 
remained following selection of NK 1.1 or Lyt-2.2 and 
immunomagnetic beads, or immunomagnetic beads alone. A. g. 
albicans growth inhibition was assessed by the incorporation 
of [3H] uridine. Data are presented as % inhibition and in-
hibitory units per 107 cells at 20% inhibition (IU). B. 
YAC-1 cytotoxicity is expressed as % cytotoxicity as judged 
by [51Cr] release and by lytic units per 107 cells at 20% 
cytotoxicity (LU). c. P815 cytotoxicity is expressed as% 
cytotoxicity as judged by [51Cr] release and by lytic units 
per 107 cells at 20% cytotoxicity (LU). *, (p<0.05) 
Significant difference of activity between either Lyt-2.2 
selected or NK 1.1 unselected rIL-2 activated populations 
compared to untreated rIL-2 activated populations, Lyt-2.2 
unselected, or NK 1.1 selected populations. **, (p<0.05) 
Significant difference of activity between either Lyt-2.2 
unselected or NK 1.1 selected rIL-2 activated populations 
compared to untreated rIL-2 activated populations, Lyt-2.2 
selected, or NK 1.1 unselected populations. Data are ex-
pressed as the mean ± S. D. of 3 independent experiments. 
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2 activated populations (p<0.05, Figure 11). In contrast, 
siqnif icant enrichment of activity against both ~. albicans 
and P815 was observed by both Lyt-2.2 selected cells (Lyt-
2.2+) and NK 1.1 unselected pr depleted cells (NK 1.1") 
(p<0.05). The activity of these populations was 
significantly enhanced (p<0.05) compared to untreated rIL-2 
activated populations, NK 1.1+ selected cells, and Lyt-2.2· 
unselected (depleted) cells. The cytotoxic activity of the 
NK 1.1· population against the YAC-1 cell line was 
significantly reduced (p<0.05) when compared to all other 
populations examined, yet retained activity. Selected and 
remaining unselected populations were examined for 
expression of Lyt-2.2 or NK 1.1 as judged by direct 
microscopic fluorescence. Lyt-2.2+ selected populations and 
NK 1.1·unselected populations contained insignificant 
percentages of NK 1.1+ expressing cells. Lyt-2.2·unselected 
populations and NK 1.1+ selected populations contained less 
than background levels of expression of Lyt-2.2 (Table III). 
These data confirm the complement-depletional studies 
and demonstrate that the Lyt-2.2+ population mediates the 
anti-~. albicans and anti-P815 activity of the rIL-2 
activated population while both Lyt-2.2+ and NK 1.1+ 
populations mediate anti-YAC-1 activity. 
Table III. Percentage of rIL-2 activated population 
expressing Lyt-2.2 or NK 1.1 following selection with 
inununomagnetic antibody. 
Effector 
population % Lyt-2. 2• % NK 1.1 
Lyt-2.2+ > 95% 4.5 ± 3. 4bc (selected) 
Lyt-2. 2- 3.1 + 1. 7d N. D. e 
(unselected) 
NK 1.1 + 5.0 + 3.6 
(selected) 
NK i.1- N. o. 
(unselected) 
a As judged by microscopic immunofluorescence. 
b Mean ± S. D. of three experiments. 
c Secondary background 4.3 ± 3.1%. 
d secondary background 5.7 ± 2.6%. 
e Not Done. 
> 95% 
4.2 + 2.2 
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g;U,d Target Inhibition of Anti-fungal and Anti-tumor 
Activity 
-
To assess whether the same cell population is capable 
of binding both fungal and tumor targets, cold target 
inhibition studies were performed. 
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In all experiments, homologous inhibitors provided 
maximum inhibition of their respective targets (Figure 12). 
In all studies, control populations for nonspecific 
inhibition were naive thymocytes. No cold target inhibition 
by thymocytes was observed in any experiment. Figure 12A 
depicts cold target inhibition of ~. albicans. Both P815 
and YAC-1 demonstrated the ability to inhibit the activity 
of rIL-2 activated populations against ~. albicans. The 
competitive activity of both tumor cell lines was 
significant when compare to that of naive thymocytes 
(p<0.05, Figure 12A). Cytotoxic activity against the YAC-1 
tumor cell line was inhibited by both the P815 tumor cell 
line and to a lesser extent by ~. albicans. The inhibition 
by both P815 and ~. albicans was significant at p<0.05 at 
the three highest ratios examined (Figure 12B). The cold 
target inhibition of the P815 cell line was nearly complete 
by the YAC-1 cell line with the inhibition significant at 
p<0.05 (Figure 12C). ~. albicans significantly inhibited 
cytotoxicity for the P815 tumor cell line (p<0.05) (Figure 
12C). To assure that the cold target populations were not 
mediating the inhibition through released factors, culture 
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Figure 12. 
Unlabeled target competition studies with g. albicans, YAC-
1, and P815. rIL-2 activated population were utilized at a 
40 : 1 effector : target ratio for % competitive inhibition. 
A. Competitive inhibition of anti-fungal activity by g. 
albicans, YAC-1, and P815 as assessed by the uridine method. 
B. Competitive inhibition of Yac-1 cytotoxicity by g. 
albicans, YAC-1, and P815 as assessed by [51Cr] release. c. 
Competitive inhibition of P815 cxtotoxicity by g. albicans, 
YAC-1, and P815 as assessed by [ 1CrJ release. Unlabeled 
homologous target inhibitors were shaded with squares 
representing g. albicans, circles representing YAC-1, and 
triangles representing P815. Thymocytes (diamonds) were 
utilized as irrelevant targets. Data are expressed as the 
mean ± s. D. of percent competitive inhibition for 3 
independent experiments. 
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Pernates from the target cell populations were collected su 
d assessed for inhibitory activity. No effect on an 
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cytotoxic or inhibitory activity was observed for supernates 
coata not shown). 
These data suggest that the rIL-2 activated population 
which binds to g. albicans also binds to P815 and YAC-1. 
Reciprocally, the rIL-2 activated population subpopulation 
which binds and mediates anti-tumor activity also binds g. 
albicans. 
Role of Cell Contact in c. albicans growth inhibition by 
rIL-2 activated population 
A· g. albicans growth inhibitory activity of cellular 
supernates 
To assess the anti-fungal activity of secreted 
substances and evaluate the necessity for cell contact in 
anti-fungal activity, rIL-2 activated population supernates 
and cellular sonicates were assessed for g. albicans growth 
inhibition. 
Supernates concentrated 75 fold from populations 
treated for 3 h with g. albicans hyphae were assessed for g. 
albicans growth inhibition (Figure 13A). 200 - 12 µl of g. 
albicans stimulated supernates displayed an anti-g. albicans 
activity in a dose dependent manner (200 µl of concentrated 
supernate is equivalent to the supernate of 3.75 x 107 
cells). Unstimulated culture supernates (concentrated 75 
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Figure 13. 
Effect of rIL-2 activated population supernates and whole 
cell sonicates upon g. albicans. g. albicans growth 
inhibition was assessed by the uridine method and presented 
as % inhibition and IU. A. Concentrated supernates (200 ul 
to 12 ul) from g. albicans treated rIL-2 activated 
population, untreated rIL-2 activated population, and super-
nates from tissue culture media containing 1500 U/ml rIL-2 
were assessed for c. albicans growth inhibition and compared 
to intact rIL-2 activated population activity. B. Activity 
of sonicates from g. albicans treated rIL-2 activated 
population, untreated rIL-2 activated population, day o 
spleen sonicates, and day o thymocytes were assessed for g. 
albicans growth inhibition at equivalent cellular ratios of 
50:1 to 1:1, and compared to the intact rIL-2 activated 
population activity. *, (p<0.05) Significant difference 
between g. albicans growth inhibition of stimulated or 
unstimulated supernates or sonicates from rIL-2 activated 
populations compared to untreated rIL-2 activated 
populations (significant decrease in inhibitory activity) or 
control populations (significant increase in inhibitory 
activity). Data are expressed as the mean ± s. D. of 3 
independent experiments. 
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fold) also possessed inhibitory activity against Q. albicans 
when compared to the inhibitory activity of supernates of 
cell culture media (with rIL-2) concentrated 75 fold 
(p<0.05). 
These data demonstrate that Q. albicans stimulated rIL-
2 activated populations secrete substances which possessed 
activity against Q. albicans. However, the anti-Q. albicans 
was 225-fold less active than the intact rIL-2 activated 
population. A finding consistent with a requirement for 
cell contact for optimal Q. albicans growth inhibitory 
activity. 
B. Q. albicans growth inhibitory activity of cellular 
sonicates 
Cellular sonicates prepared from rIL-2 activated 
populations produced an enhanced Q. albicans growth 
inhibition when compared to the concentrated supernates 
(Figure 13). Cell sonicates, equivalent to splenocyte 
numbers utilized for assessment of activity, from either Q. 
albicans stimulated or unstimulated rIL-2 activated 
populations produced moderate inhibitory effects against Q. 
albicans. The activity of either stimulated or unstimulated 
sonicates was significantly higher (p<0.05) than sonicates 
from either day o splenocytes or thymocytes. In contrast, 
the activity of either stimulated or unstimulated sonicates 
was significantly less (p<0.05) than the activity of rIL-2 
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activated populations. 
These data demonstrate that cellular sonicates are one 
sixth as efficient in mediating ~. albicans growth 
inhibition as the intact population, indicating an intact 
cell is required for maximum ~. albicans growth inhibition. 
c. Role of protease inhibitors in anti-fungal and anti-
tumor activity 
Contact and an intact cell are required for maximally 
efficient anti-fungal activity. Proteases are associated 
with contact-mediated cytotoxic activity for tumor cells. 
Therefore, three protease inhibitors were analyzed for their 
ability to inhibit the anti-tumor and anti-fungal activity 
of rIL-2 activated populations. 
Figure 14 depicts the inhibition of anti-tumor and 
anti-fungal activity during treatment with the protease 
inhibitors, aprotinin 10%, PMSF 300 ug/ml, and TAME lOuM. 
Aprotinin produced a marked (p<0.05) decrease in activity 
for all targets examined when compared to rIL-2 activated 
populations. PMSF treated rIL-2 activated populations 
displayed numerically reduced activity for both ~- albicans 
and P815 when compared to untreated rIL-2 activated 
populations. PMSF treated rIL-2 activated populations were 
unaffected in their activity for YAC-1. In contrast to PMSF 
and aprotinin, TAME treated rIL-2 activated populations 
showed no inhibition of anti-fungal or anti-tumor activity 
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Figure 14. 
Fungal growth inhibition and tumor cell cytotoxicity of rIL-
2 activated population during treatment with protease in-
hibitors. rIL-2 activated populations and targets, as well 
as both g. albicans alone and rIL-2 activated populations 
alone were treated with aprotinin 10% (APRO), TAME lOuM 
(TAME), and PMSF 300 ug/ml (PMSF), or untreated (day 7). A. 
g. albicans growth inhibition was assessed by the incorpora-
tion of [3H] uridine. Data are presented as % inhibition 
and inhibitory units per 107 cells at 20% inhibition (IU). 
B. YAC-1 cytotoxicity is expressed as % cytotoxicity as 
judged by [51 Cr] release and by lytic units per 107 cells at 
20% cytotoxicity (LU). c. P815 cytotoxicity is expressed as 
% cytotoxicity as judged by [51Cr] release and by lytic units 
per 107 cells at 20% cytotoxicity (LU). Targets without 
effectors were treated with appropriate protease inhibitors 
and utilized to determine maximal incorporation of [3H] 
uridine for inhibition calculations. No differences in 
uptake of [3H] uridine were observed between treated targets 
without effectors and untreated targets without effectors 
(p>0.05), nor did treated effectors without targets display 
loss of viability as judged by trypan blue. *, (p<0.05) 
Significant difference between activity of aprotinin treated 
rIL-2 activated populations compared to untreated rIL-2 
activated populations. Data are expressed as the mean ± s. 
D. for 3 independent experiments. 
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against either YAC-1, P815 or g. albicans as compared to the 
activity of untreated rIL-2 activated populations. The 
protease inhibitors were not directly cytotoxic. 
pretreatment of rIL-2 activated populations with these 
protease inhibitors for 1 h failed to reduce the anti-fungal 
and anti-tumor activity (Data not shown). 
These data demonstrate the anti-fungal and anti-tumor 
activity of rIL-2 activated populations to be affected by 
the serine protease inhibitor, aprotinin. 
o. Effect of protease inhibitors on cellular sonicate and 
supernate activity 
Sonicates and supernates treated with protease 
inhibitors from g. albicans stimulated populations were 
assessed for g. albicans growth inhibitory and anti-tumor 
cytotoxic activity either with or without the protease 
inhibitors PMSF (300 ug/ml) or aprotinin (10%) (Figure 11). 
g. albicans growth inhibitory activity of rIL-2 
activated population supernates (8.5 ± 2.5 IU) was not 
different when compared to supernates of rIL-2 activated 
populations treated with either PMSF or aprotinin. No 
difference in tumor cytotoxic activity was displayed by rIL-
2 activated population cell supernates {14.3 ± 2.6 LU for 
YAC-1, 12.2 ± 2.3 LU for P815) compared to rIL-2 activated 
population supernates treated with either PMSF or aprotinin. 
Cellular sonicates of the rIL-2 activated population 
97 
Figure 15. 
Fungal growth inhibition and tumor cell cytotoxicity of cell 
supernates and sonicates during treatment with protease in-
hibitors. Cell sonicates {open symbols) at 50:1 to 6:1 
equivalents and concentrated supernates (closed symbols) ex-
pressed at 200 ul to 50 ul, from ~. albicans stimulated rIL-
2 activated populations, were treated with aprotinin 10% ( , 
) PMSF 300 ug/ml ( , ) or untreated ( , ). A.~. albicans 
growth inhibition was assessed by the incorporation of [3H] 
uridine. Data are presented as % inhibition and inhibitory 
units per 107 cells at 20% inhibition (IU). B. YAC-1 
critotoxicity is expressed as % cytotoxicity as judged by 
( 1Cr] release and by lytic units per 107 cells at 20% 
cytotoxicity (LU). c. P815 cytotoxicity is expressed as% 
cytotoxicity as judged by [51Cr) release and by lytic units 
per 107 cells at 20% cytotoxicity (LU) . Data are expressed 
as the mean ± s. D. for 3 independent experiments. 
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demonstrated activity against all target populations (63.1 ± 
g.3 IU for~- albicans, 105.5 ± 13.2 LU for YAC-1, and 115.2 
± 1J.6 LU for P815). The protease inhibitors had no effect 
on the sonicates. 
These data indicate that the protease inhibitor acts 
only against the intact cell and not any soluble factor 
released from the cell. 
DISCUSSION 
Fungal infections in general and g. albicans infections 
in particular are important causes of morbidity and 
mortality in immunocompromised individuals. This study 
evaluated a novel mechanism by which to limit the 
development of fungal disease. It has been very difficult 
to understand the means by which the mammalian host deals 
with limiting the growth of fungal hyphae which reach 
lengths of 100 µm or larger, in vivo (Soll, 1985). It is 
the hypothesis of this study that lymphocytes influence the 
growth of fungal hyphae. If true, then such cells may 
provide an important host defense mechanism by which fungi 
may be limited when normal defense mechanisms are disrupted. 
It was the purpose of this investigation to clearly identify 
the immunological nature, functional activity and laboratory 
conditions by which to generate anti-fungal effector lym-
phocytes. This identification will permit a direct 
assessment of the potential in vitro biological activity of 
the lymphocyte cell population and will serve as the 
groundwork for a better understanding of the mammalian host 
response to g. albicans. 
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A review of the literature shows that a correlation 
exists between in vivo resistance to g. albicans, the 
production of IL-2 and IFN gamma, and the genotype of 
specific inbred strains of mice (Ashman et al., 1990). In 
that study, resistance to g. albicans did not correlate with 
phagocytic cell activity of the murine strains (Marquis et 
al., 1986). Therefore, non-phagocytic cell populations from 
C57Bl/6 mice were evaluated for g. albicans growth 
inhibition. Due to the importance of the hyphal form of the 
fungus in disseminated infections, g. albicans growth 
inhibition was assessed against hyphae. Lymphoid cells with 
functional and phenotypic characteristics similar to 
"activated" T lymphocytes were found to inhibit the growth 
of the hyphal form of g. albicans (Figures 9-11). Lymphoid 
cells derived from mice and immediately assessed for hyphal 
growth inhibition showed little or no activity (Figures 1-
2). This finding is consistent with previously published 
data {Djeu et al., 1988; Djeu and Blanchard, 1987). 
However, significant hyphal growth inhibition was observed 
when lymphoid cells were cultured with high concentrations 
of recombinant interleukin-2 (rIL-2) (Figures 3-7). Growth 
inhibitory activity was mediated by non-adherent lymphocytes 
which had the capacity to lyse the NK susceptible YAC-1 cell 
line and the NK resistant P815 cell line. Phenotypic marker 
selection showed the lymphocyte cell population to express 
Thy-1.2, Lyt-2.2, and ASGM-1. Other investigators have 
102 
failed to demonstrate lymphocyte mediated activity against 
g. albicans (Baccarini et al., 1983; Djeu and Blanchard, 
1987). Those investigators have either used freshly iso-
lated lymphocytes or lymphocytes activated with low 
concentrations of cytokines to inhibit ~. albicans growth 
(Baccarini et al. 1983; Djeu and Blanchard, 1987). The 
results of this study are consistent with those previous 
observations but demonstrate that greater concentrations of 
rIL-2 are required to "activate" or enhance the capacity of 
lymphocytes to mediate growth inhibition of the fungus. 
With greater quantities of rIL-2 it is possible to 
"activate" lymphocytes, and/or expand a population of 
lymphokine activated cells which mediate fungal growth 
inhibition. 
Multiple methodologies have been published with which 
to assess activity against ~. albicans including; 51Cr 
release from the fungus, and direct microscopic examinations 
(Baccarini et al., 1985; Hashimoto, 1983). Although 
accepted methodologies, neither permits easy assessment of 
large sample numbers. Therefore, an alternative method was 
developed by which to measure growth inhibitory activity. 
This procedure is based upon previously published 
methodology (Yamamura et al., 1977), but includes an 
extremely important additional step which enzymatically 
removes the adherent ~. albicans from plastic surfaces. The 
enzyme employed is lyticase. Lyticase cleaves beta 1,3 
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linkages of glucose, which are found in glucan, a major 
constituent of the cell wall of g. albicans. Alteration of 
the cell wall by lyticase reduces the binding capacity of g. 
albicans to plastic (Kennedy et al., 1989; Hazen, 1989), and 
allows for easy harvest of the fungi with a PhD cell 
harvester. Therefore, large numbers of experimental samples 
can be processed in a manner similar to the harvesting 
procedure for lymphoproliferation assays. The assay 
employed measures the incorporation of [ 3H] uridine by g. 
albicans as an index of fungal cell growth. Very little is 
known about the metabolism of RNA during g. albicans growth. 
Wain et al. (1976) demonstrated that the RNA content, as 
measured by (3H] uridine uptake by g. albicans, increases 
continuously throughout the cell cycle. The predominant 
form of RNA found in g. albicans is ribosomal (Anderson and 
Soll, 1984). No measurement of messenger RNA synthesis have 
been reported. Nevertheless, following the conclusion of 
the three hour co-incubation period, [3H] uridine uptake is 
at a steady state of accumulation (Soll, 1985). The 
inhibition of [3H] uridine uptake directly reflects 
alteration of normal g. albicans growth (Soll, 1985). The 
assay system utilized takes advantage of this steady state 
incorporation of uridine and with the use of lyticase and 
the PhD cell harvester, is a simple, convenient and 
reproducible procedure. Furthermore, the obtained 
experimental results are similar to those of previously 
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published methodologies (Baccarini et .sU..., 1985; Hashimoto, 
1983; Beno and Mathews, 1990). 
Anti-g. albicans activity is presented as a percent 
inhibition of hyphal growth as described previously (Nabavi 
and Murphy, 1985). The hyphal form predominates in tissues 
infected with g. albicans and is therefore considered to be 
the most relevant for examination. The assay utilized for 
assessment of growth inhibitory activity was developed to 
reflect inhibition within a three hour period. Whether the 
assay truly measures growth inhibition or is in fact a 
measure of direct cytotoxic activity is unknown. The 
decrease in countable disintergrations in the experimental 
samples might reflect cytotoxic activity. However this can 
not be directly assessed by the results of this assay. The 
decrease in countable disintergrations can only be as-
sociated with a change in the steady state incorporation of 
[ 3H] uridine. The decrease in radioisotopic incorporation 
has been associated with a decrease in RNA accumulation, 
protein synthesis, and cell proliferation (Anderson and 
Soll, 1984). Whether this is inhibition of the hyphal 
fragments resulting from damage of one or more of the 
individual segments of the organism or death of the entire 
organism is unknown. Regardless, the g. albicans activity 
does not lead to complete destruction of the fungi in that 
countable disintergrations are incorporated in all 
experimental cases. Therefore, the lowered incorporation of 
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[3HJ uridine is defined as growth inhibition. 
NK activity (as judged by anti-YAC-1 cytotoxicity) was 
present in murine splenocytes (Figure 1). In contrast, no 
g. albicans growth inhibition was detectable in murine 
splenocytes (Figure 1) . These findings are consistent with 
previous studies which indicated no anti-g. albicans 
activity in murine splenocyte populations (Vecchiarelli et 
al., 1985; Zunino and Hudig, 1988). NK activity is 
associated with a morphological cell type, the large 
granular lymphocyte (LGL) (Ortaldo and Longo, 1988). LGL 
can been isolated in high purity from discontinuous Percoll 
gradients or enriched by passage over nylon wool columns 
(Hidore and Murphy, 1986). To enrich for NK activity, day 
zero splenocytes were subjected to discontinuous percoll 
separation. Low density fractions which contained high 
concentration of LGLs showed a significant increase in NK 
activity when compared to the unseparated splenocyte 
population. No increase in g. albicans growth inhibition 
was observed with the LGL enriched cell population (Figure 
2). Splenocytes were also depleted of adherent cells by 
passage over nylon wool columns as well as by adherence to 
plastic. NK enrichment and macrophage depletion by these 
procedures resulted in cells with no g. albicans growth 
inhibitory activity, despite an increase in NK activity when 
compared to untreated splenocyte populations. These data 
are consistent with previous studies indicating no 
enrichment of Q. albicans growth inhibition in cell 
populations enriched for NK activity (Djeu et al., 1988; 
zunino and Hudig, 1988). 
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Previous studies using human LGL isolated from PBMCs 
failed to demonstrate g. albicans inhibitory activity 
following activation with low levels of rIL-2 (Djeu and 
Blanchard, 1987) • rIL-2 activated human LGLs did not 
produce growth inhibition of g. albicans following 
activation with 100 U/ml rIL-2 for 18 h (Djeu and Blanchard, 
1987). The current study found that murine splenocytes 
activated with 1500 U rIL-2 for 24 h showed no significant 
increase in g. albicans inhibitory activity despite a 
significant increase in NK activity (Figure 3). Splenocytes 
cultured for one day in culture medium without rIL-2 had no 
activity against g. albicans or P815 and the level of 
activity against YAC-1 was significantly lower than either 
day zero or day one. These data are consistent with 
previous findings demonstrating that splenocytes activated 
for a short time period with rIL-2 possess an enhanced NK 
activity but do not mediate g. albicans growth inhibition 
(Djeu and Blanchard, 1987). However, the results of this 
dissertation do demonstrate that with increased 
concentrations of rIL-2, the capacity to inhibit g. albicans 
is acquired by lymphocytes and is associated with the 
capacity to lyse NK sensitive and insensitive tumor cell 
lines (Figures 4, 5). These data are unique. No other 
investigations have identified an enhanced &· albicans 
growth inhibition following rIL-2 activation. 
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This study sought to identify the length of time 
required for in vitro culture to acquire maximal &. albicans 
growth inhibitory activity. The appearance of the &· 
albicans growth inhibition coincided with the development of 
cytotoxic activity for the NK resistant tumor target, P815, 
and enhanced activity against the NK susceptible tumor 
target, YAC-1 (Figure 6). To identify the length of culture 
required for maximal cell recovery following activation with 
rIL-2, cell recovery and proliferation rate were evaluated. 
Splenocyte recoverability dramatically decreased following 
two days in culture with rIL-2 (Figure 7). Previous studies 
have demonstrated the loss of B lymphocytes and T helper 
lymphocytes over time in culture with rIL-2 (Peace et al., 
1988). In the current study, as the recoverability 
decreased the rate of proliferation increased. 
Proliferation began at day two and peaked by day four. 
Proliferation failed to continue after day seven in this 
study. This finding is similar to the studies of Mule et 
al. (1987), who found no proliferation following eight days 
in culture with rIL-2. Splenocytes activated in rIL-2 for 
seven days were chosen for further study because both 
maximal cell numbers and anti-fungal activity were observed 
at this time period. 
The extended culture period may permit the development 
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of a population with broad tumoricidal reactivity as 
evidenced by the concomitant appearance of cytotoxic 
activity for the NK insensitive cell line, P815. The 
development of this population could be the consequence of 
several factors. First of all, expansion of rIL-2 
responsive populations which mediate c. albicans growth 
inhibition and anti-tumor activity may occur. Yang et al. 
(1986) found a concomitant decrease in the number of IL-2 
unresponsive lymphocytes in such culture which paralleled an 
increase in the number of lymphocytes which were responsive 
to rIL-2. Alternatively, activation of an existing anti-
fungal cell population may require an extended culture 
period for maximal activity. Studies by Merluzzi (1985) 
indicate that at least three days of rIL-2 activation are 
required for induction of anti-P815 activity with seven days 
required for maximal activity. Other studies of rIL-2 
activation demonstrate that three to five days of culture 
are required for maximal tumoricidal activity (Grimm et al., 
1982; Lafreniere et al., 1986). The results of this 
dissertation did not demontrate an absolute requirement for 
the expansion of the rIL-2 activated population which 
mediates the ~- albicans growth inhibition. However, the 
expansion of this populaiton cannot be dismissed due to the 
observed changes in cellular proliferation, cell recovery, 
and cellular phenotype during activation with rIL-2 (Figure 
7, Table I). The results of this dissertation are 
consistent with the activation of a rIL-2 activated 
population which mediates ~. albicans growth inhibition. 
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Thus far this investigation has demonstrated that 
following extended activation with rIL-2, a population of 
lymphocytes arises which mediate ~. albicans growth 
inhibition. The seven day rIL-2 activated cell population 
also mediates anti-tumor activity against both the NK-
sensitive tumor cell line YAC-1, and the NK-insensitive 
tumor cell line P815. ~. albicans growth inhibition does 
correlate with the acquisition of both anti-P815 and 
enhanced anti-YAC-1 activity suggesting that a MHC-
unrestricted cytotoxic lymphocyte population is a portion of 
the cell population responsible for the observed ~. albicans 
growth inhibition (Figures 3-5). Other studies of 
lymphocyte mediated anti-~. albicans activity have not 
observed anti-fungal activity because the requisite 
activation and expansion of the anti-fungal cell population 
was not permitted (Vecchiarelli et al., 1985; Zunino and 
Hudig, 1988). The current study demonstrates that seven 
days are required for maximal activation with 1500 U rIL-2. 
The results of this study demonstrate that activation 
of splenocytes with rIL-2 augments not only the anti-tumor 
and anti-fungal activity of splenocytes, but also alters the 
phenotypic makeup of the cell population (Table I). 
Increased numbers of cells expressed the specific surface 
markers Thy-1.2, ASGM-1, Lyt-2.2, and NK 1.1 while cellular 
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expression of Ig and L3T4 decreased to background levels. 
This phenotypic marker expression has been demonstrated 
previously to be a consequence of rIL-2 activation (Yang et 
gj.., 1986). 
Previously, rIL-2 activation of lymphocytes has been 
shown to induce MllC-unrestricted cytotoxic reactivity in 
vitro, which is mediated by lymphocytes expressing both Thy-
1. 2 and ASGM-1 phenotypic markers (Ballas et al., 1987; 
Merluzzi et al., 1986). Thy-1.2 is known to be expressed by 
lymphocytes with broad cytotoxic activity (Yang et al., 
1986; Thiele and Lipsky, 1989) while ASGM-1 is present on a 
variety of cell types (Mule et al., 1989) and it's 
expression has been shown to correlate directly with 
activation of MllC-unrestricted cytotoxic lymphocytes (Stout 
et al., 1987). Within the limits of experimental error, all 
seven day rIL-2 activated populations in this study 
expressed Thy-1.2 (Table I). In a similar manner, ASGM-1 
was shown to be expressed by nearly all cells comprising the 
rIL-2 activated population (Table I). Therefore, ASGM-1 and 
Thy-1.2 are expressed simultaneously by the lymphocytes 
which comprise the rIL-2 activated population. This data is 
consistent with the scientific literature and the clear 
expression of both ASGM-1 and Thy-1.2 by the rIL-2 
activated population. 
The results of flow cytometric analysis (Table I) 
suggested the possible differential expression of Lyt-2.2 
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and NK 1.1 by cells within the rIL-2 activated population. 
Anti-NK 1.1 specifically identifies mature NK and other MHC-
unrestricted cytotoxic lymphocytes in certain murine 
strains, including C57Bl/6 (Koo and Peppard, 1984}, whereas 
antibody to Lyt-2.2 identifies cytotoxic T lymphocytes 
(Kalland et al., 1987). The current investigation sought to 
determine whether the anti-fungal activity segregated with a 
particular cellular phenotype within the rIL-2 activated 
population of cells. The differential expression of Lyt-2.2 
and NK 1.1 was exploited to identify the phenotypic 
character of the rIL-2 activated population which mediates 
g. albicans growth inhibition. The results of those studies 
suggest that rIL-2 activated population mediating c. 
albicans growth inhibition express Lyt-2.2 and not NK 1.1 
(Figures 6, 7, and 8). Differential expression of NK 1.1 
and Lyt-2.2 within the rIL-2 activated population is similar 
to the studies of Peace et al. (1988) who showed LAK cells 
were divided into at least two mutually exclusive subsets, 
1) a cytotoxic T lymphocyte (Lyt-2.2+, NK 1.1*) with MHC-
unrestricted cytotoxic activity and 2) a NK (Lyt-2.2·, NK 
1.1+) cell population with MHC-unrestricted cytotoxic 
activity. The results of this study show that these two 
separate and distinct subpopulations exist within the seven 
day rIL-2 activated population. The Lyt 2.2+ lymphocyte 
population mediates the anti-fungal activity of the seven 
day rIL-2 activated population. 
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This study has demonstrated anti-Lyt-2.2 and complement 
treatment to obliterate the growth inhibitory activity of 
the rIL-2 activated population for the hyphal form of ~. 
albicans. This treatment also reduced the lytic activity of 
the cell population for P815 but not YAC-1 (Figure 7). 
These data demonstrate the Lyt-2.2+ population to be capable 
of activity against both~. albicans and P815. NK 1.1 an-
tibody and complement depleted cell populations mediated 
significantly (p<0.05) increased~. albicans growth 
inhibition. Statistical analysis of the inhibitory units 
(IU) reveals significant differences between the cells 
treated with NK 1.1 and complement and complement alone, 
despite no apparent visual difference in the effector to 
target ratio data. In calculating the IU based on the lytic 
unit calculation, these data are significant because of the 
inclusion of the data at 6:1 effector to target ratio. The 
inclusion of this data alters the linear slope of the line 
which is used for IU calculation. Comparisons of NK 1.1 and 
complement treated cells with cells treated with complement 
alone reveal numerical differences in ~. albicans growth 
inhibition. These differences indicate that the loss of NK 
1.1+ cells results in an increase in~. albicans growth 
inhibitory activity. These data calculated as IU also 
demonstrate that lymphocytes expressing the NK 1.1 
determinant do not mediate the ~. albicans growth inhibition 
(Figure 7). 
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Although stringent conditions for antibody and 
complement mediated depletions were utilized, the com-
pleteness of these depletions may not be absolute (Mule et 
al., 1989; Kalland et al., 1987). Furthermore, antibodies 
used for such depletion may interfere with cellular 
functional activity (Peace et al., 1988). It is difficult, 
and perhaps impossible, to obtain a totally pure cell 
populations with any cell separation procedure, and it is 
even more difficult to accurately quantify the possible 
contribution of contaminating cells (Kalland et al., 1987). 
In this study, a small percentage of positively labelled 
cells were observed by direct fluorescent microscopy to 
remain in depleted cell populations (Table II). Thus, any 
remaining low levels of activity against g. albicans and 
P815 might be the result of residual cell populations not 
eliminated during complement-mediated depletions. However, 
the complement depletion studies do suggest that Lyt-2.2+ 
cells mediate g. albicans growth inhibition. Confirmation 
of these data was sought by positive selection of the same 
phenotypes. 
Figure SA demonstrates that the Lyt-2.2+ rIL-2 
activated subpopulation, selected by magnetic antibody and 
anti-Lyt-2.2+, mediated significantly enhanced g. albicans 
growth inhibition when compared to unselected rIL-2 
activated cell populations. Concomitant with the enhance-
ment of g. albicans growth inhibition was an enrichment in 
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anti-PS15 activity (Figure SC). These data are consistent 
with the Lyt-2.2+ cell population mediating activity against 
both g. albicans and the PS15 tumor cell line. No dif-
ferences in anti-YAC-1 activity between the Lyt-2.2+ and 
Lyt-2.2· separated populations were observed (Figure SB). 
Previous studies have demonstrated rIL-2 activated 
lymphocytes expressing Lyt-2.2+ to be capable of anti-YAC-1 
cytotoxicity (Kalland et al., 19S7; Gunji et gl., 19S9) as 
well as anti-PS15 activity (Sensi et al., 1990). 
The NK 1.1-populations showed decreased anti-YAC-1 ac-
tivity (Figure SB). This is consistent with previous 
studies which demonstrate a majority of anti-YAC-1 activity 
resides within the NK 1.1+ population (Kalland et al., 
1987). The absence of enriched anti-YAC-1 activity in the 
NK 1.1+ population is also consistent with previous studies 
which demonstrate both NK 1.1+ and Lyt-2.2+ populations to 
be capable of anti-YAC-1 cytotoxicity (Peace et al., 19S8; 
Gunji et al., 1989). Figure SA shows decreased g. albicans 
growth inhibition by the NK 1.1+ subpopulation selected by 
magnetic antibody compared to that of the Lyt-2.2+ selected 
subpopulations. NK 1.1+ selected populations showed sig-
nificantly decreased g. albicans growth inhibition when com-
pared to untreated rIL-2 activated populations. Concomitant 
with the decrease in g. albicans growth inhibition activity 
was a decrease in anti-P815 activity (Figure SC). These 
data are consistent with the Lyt-2.2+ cell population 
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mediating activity against both ~- albicans and the P815 
cell line. No anti-fungal activity was observed for NK 1.1+ 
selected cells. 
Lyt-2.2+ expressing cells have been demonstrated to 
mediate anti-P815 activity (Sensi et al., 1990). This 
finding is confirmed by the current study. However, the 
lack of NK 1.1+ mediated anti-P815 activity was surprising. 
studies have demonstrated NK 1.1+ pan-cytotoxic activity 
(Ballas and Rasmussen, 1990). Those investigations employed 
the NK resistent targets, EL-4 and CL27a but not the P815. 
The lack of NK 1.1+ effector activity against P815 may 
relect differences between these distinct target cell 
populations. However, the data unequivocally demonstrates 
the NK 1.1+ cell population to be unable to mediate anti-
P815 activity (Figure 11). 
The magnetic selection of rIL-2 activated 
subpopulations was completed on the sixth day of activation 
with rIL-2. This methodology was necessitated by the nature 
of the selection process. The major consideration was the 
possible inhibition of biological activity due to stearic 
hinderance by antibody-magnetic bead complexes on the cell 
surface. The differential functional activities observed 
with subpopulations separated magnetically attests to the 
appropriateness of the approach and its' superiority to that 
of complement-mediated, antibody depletions. Complement-
mediated cell lysis, as compared to magnetic separation, 
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while based on the same spectrum of available antibodies is 
more time consuming, is restricted to cell depletion, and is 
less efficient with respect to the viability and purity of 
the resulting subpopulation (Pflueger et gl., 1990). 
Therefore, populations selected by the magnetic separation 
technique were a more reliable index of biological activity. 
The combination of data from Figures 6, 7, and 8 
demonstrates that Lyt-2.2 and NK 1.1 are not expressed on 
the same cells within the seven day rIL-2 activated cell 
population. Both the total percentage of cells expressing 
each marker in the rIL-2 activated population along with the 
concurrent increase and decrease in the antibody treated 
populations argues for separate populations of Lyt-2.2+ and 
NK 1.1+ within the total Thy-1+ and ASGM-1+ population. 
although a minor population expressing both Lyt-2.2 and NK 
1.1 may exist. The~. albicans growth inhibition activity 
resides in the rIL-2 activated population which expresses 
ASGM-1, Thy-1.2 and Lyt-2.2, but not NK 1.1. 
These results are consistent with one cell population 
mediating both an anti-~. albicans and an anti-P815 activity 
as well as an anti-YAC-1 activity. To assess whether the 
anti-fungal effector cells within the rIL-2 activated 
population also bind tumor targets, cold target inhibition 
studies were performed. Homologous cold targets mediated 
complete inhibition of growth inhibitory activity of ~. 
albicans as well as cytotoxic activity against tumor targets 
117 
(Figure 13). Heterologous cold targets inhibited biological 
activity for either tumor or fungal targets in a competitive 
and reciprocal manner. These data provide evidence that the 
rIL-2 activated population possesses the ability to 
recognize and bind all three targets. The absolute 
resolution of whether a population within the rIL-2 
activated population mediates activity against both tumor 
targets and ~. albicans will require the preparation of a 
cloned rIL-2 activated population. At this point, no known 
functional clone with similar activity to rIL-2 activated 
population is available and attempts to obtained cloned 
populations have not succeeded. 
The findings of this study suggest recognition of 
targets, as judged by incomplete and varying levels of cold 
target inhibition, is not identical. However, similarities 
in recognition and binding do exist. The extent of in-
hibition of g. albicans activity was greater by P815 than 
YAC-1 suggesting the rIL-2 activated population which binds 
~. albicans is more reactive with P815 than with YAC-1. The 
greater inhibition by P815 might not necessarily reflect 
variation in target recognition, but rather might be a 
binding characteristic of the rIL-2 activated population. 
The rIL-2 activated population which mediates g. albicans 
growth inhibition might be more adhesive for certain tumor 
targets than cell populations which do not mediate ~. 
albicans growth inhibition. The phenotyping data indicates 
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at least two populations possess activity against YAC-1, 
therefore the incomplete inhibition mediated by YAC-1 might 
occur because both subpopulations bind YAC-1 while only one 
subpopulation of the rIL-2 activated population binds g. 
albicans and YAC-1. Isolation of the Lyt-2.2+ population 
and assessment of cold target inhibition is required to 
assess this hypothesis. The reciprocal inhibition of anti-
YAC-1 activity by g. albicans indicates partial recognition 
of g. albicans by a portion of the rIL-2 activated 
population which mediates activity against YAC-1. The 
inhibition is not complete, further suggesting other rIL-2 
activated populations, besides those reactive with g. 
albicans, mediate activity against YAC-1. P815 partially 
inhibits YAC-1 activity, which is consistent with one of the 
two cytotoxic populations showing activity against YAC-1. 
The c. albicans inhibition of YAC-1 activity is less than 
that of P815 competitive inhibition. The finding of 
stronger inhibition by P815 than g. albicans suggests more 
similarity between the tumor targets than the fungal/tumor 
interaction. Alternatively, effector to target binding 
might occur through different cell surface receptors. Cold 
target inhibition studies of anti-P815 activity revealed 
that YAC-1 almost completely inhibits cytotoxic activity, 
suggesting recognition of both tumor populations by rIL-2 
activated populations. The above data indicate that the 
rIL-2 activated population which mediates g. albicans growth 
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inhibition possesses the ability to bind tumor targets. 
However, the binding of this population to tumor targets is 
not as easily inhibited with ~- albicans as with tumor 
competitors. 
The incomplete cold target inhibition observed by 
heterologous targets may be explained by several factors. 
The lower inhibitory activity of e. albicans tumor target 
inhibition may result from the heat inactivation of ~­
albicans. Affected heat labile receptors (Bouchara et al., 
1990) involved in recognition might alter binding of e. 
albicans. Alteration of receptors utilized in binding might 
lower the potential binding activity of the hyphae thus 
decreasing surface receptors, leading to less cold target 
inhibitory capability. Killing the ~. albicans was 
necessitated for several reasons. First of all, live ~. 
albicans possess the ability to incorporate released [5ter] 
from the target cells. This would alter the amount of 
countable [5ter] in the supernate thereby leading to a false 
diminution of cytotoxic activity. Secondly, ~- albicans 
growth would alter the effector to target ratio during the 
assessment of cytotoxicity. Another consideration is the 
possible release of factors by ~. albicans which may alter 
the binding and/or cytotoxic mechanism of tumor activity. 
Incomplete inhibition of ~. albicans activity by cold tumor 
targets may also result from the characteristic growth of ~­
albicans in culture. The growth and elongation of ~. 
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albicans is accompanied by expansion of the hyphal length in 
culture. Growth increases the total surface area of the 
hyphae, allowing expression of more receptors for which rIL-
2 activated populations may bind and mediate anti-fungal 
activity. As the assay continues the targets become larger, 
providing more binding sites and in effect, additional 
targets. Alternatively, the adherence of the hyphae on the 
plastic surf aces may provide a mechanism which allows 
preferential binding of rIL-2 activated populations to ~. 
albicans rather than the tumor targets. Seeded and anchored 
c. albicans might preferentially enhance rIL-2 activated 
population binding. Another possible explanation is the 
construction of the ~. albicans hyphae. It consists of 
separate organisms within the hyphae joined by an incomplete 
septum (Soll, 1985). Multiple hits on each hyphae may be 
required for growth inhibitory activity. This may force the 
rIL-2 activated population to remain longer on each hyphae 
before growth inhibition is observed. Furthermore, the 
mechanism of inhibition may require a longer time period 
before growth inhibition is observed and once bound, rIL-2 
activated population may not dissociate from the cell wall 
and locate another target as quickly as in a tumor system. 
The incomplete inhibition of the fungus by rIL-2 activated 
populations affecting tumor targets could be the result of 
these physical and kinetic differences in ~. albicans-rIL-2 
activated population binding compared to tumor cell-rIL-2 
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activated population binding. In contrast to the simple 
plasma membrane where direct rIL-2 activated population-
tumor cell interactions occur, the outer surface of fungi is 
substantially more complex. Studies of NK-cyrptococcal 
interactions have shown NK-cyrptococcal binding requires two 
hours prior to initiation of anti-fungal activity while NK-
YAC-1 binding require only 20 minutes (Murphy, 1989). 
Furthermore, Cryptococcus neoformans conjugate formation is 
smaller, does not appear to interdigitate, and is generally 
much less intimate than is the broad area of interdigitating 
membrane contact observed in NK-tumor cell conjugates 
(Hidore et al., 1990). The interaction of the rIL-2 
activated population with g. albicans might also require a 
longer time period for binding and initiation of anti-fungal 
activity thereby leading to the reduced competitive 
inhibition observed with g. albicans. 
The inhibition of biological activity by heterologous 
targets is statistically significant and demonstrates that 
both c. albicans and tumor cells competitively and 
reciprocally inhibit the activity of the rIL-2 activated 
population. These data demonstrate that an effector 
population within the rIL-2 activated population recognizes 
and mediates activity for two diverse target cell popula-
tions, c. albicans and tumor cells. Previous studies of 
fungal interactions of both cryptococcus neof ormans (Hidore 
et al., 1990) and C. albicans (Zunino and Hudig, 1988) have 
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demonstrated the ability of fungi to cold target inhibit NK 
activity. The current study does not imply similar 
mechanisms of binding, it does suggest that rIL-2 activated 
population possess the ability to bind all three targets in 
a competitive manner. Furthermore, the activity of the rIL-
2 activated population is inhibited by each of these 
targets, suggesting that the rIL-2 activated population 
mediates activity against each of these target populations. 
The ability to bind all three targets, combined with proven 
activity against all three targets suggests a broad 
recognition and reactivity of the rIL-2 activated 
population. 
The mechanism of g. albicans growth inhibition is 
either mediated by direct cell contact or indirectly through 
secreted factors. The demonstration of recognition and 
binding of rIL-2 activated populations to g. albicans 
suggests the anti-fungal activity to be contact mediated. 
Therefore, this became the hypothesis for a series of 
experiments. A method for limiting cell contact between 
effector and target cells, while allowing interaction of 
soluble factors was unavailable. Therefore, an assessment 
of absolute contact could not be accomplished. 
A series of experiments was conducted to assess 
indirectly the role of cell contact in g. albicans growth 
inhibition. The first of these experiments examined whether 
cellular supernates from rIL-2 activated populations 
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roediated growth inhibition against g. albicans. 
unconcentrated culture supernates from rIL-2 activated 
populations possessed no growth inhibitory activity for g. 
albicans. Culture supernates were concentrated 75 fold and 
assessed for g. albicans growth inhibition (Figure 9). rIL-
2 activated populations were stimulated with g. albicans in 
an attempt to induce the release of growth inhibitory 
molecules. Stimulated and concentrated supernates possessed 
a greater anti-fungal activity than unstimulated and 
concentrated supernates. However the activity was roarkedly 
less than that of the intact cell population (p<0.05). The 
stimulation of rIL-2 activated populations with g. albicans 
increased growth inhibition, but coropared to intact cells, 
the inhibitory activity was negligible. These data are 
consistent with the hypothesis that contact is required for 
maximal g. albicans growth inhibition. Secreted molecules 
are not the most efficient mechanism of anti-fungal or anti-
tumor activity (Theile and Lipsky, 1989; Murphy, 1989). 
Minimal g. albicans growth inhibition by cell 
supernates suggests that growth inhibitory activity is most 
efficient when cell associated. Previous findings have 
demonstrated that LAK cells release membrane-damaging agents 
which remain cytotoxic for glial cells outside the contact 
area of effector target conjugates (Jaaskelainen et al., 
1990). However tumoricidal studies similar to this 
dissertation failed to demonstrate nonspecif ically released 
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cytotoxins which generate comparable levels of activity to 
intact effector populations {Thiele and Lipsky, 1989). 
The lack of supernate activity may be a consequence of 
a number of factors, e.g., the process of concentrating the 
freshly harvested supernates required three hours. 
Proteases may have destroyed functional activity of possible 
secreted cytotoxins in the fractions (Theile and Lipsky, 
1988). Alternatively, the target cell, g. albicans, may be 
induced by the concentrated supernates to release a variety 
of proteolytic enzymes {Wilton and Lehner, 1981). The 
proteolytic enzymes may act in a protective manner to 
inactivate anti-g. albicans factors which are present within 
the concentrated supernate (Domer, 1989). 
The concentration of rIL-2 within the media is not 
inhibitory to the measured activity since concentrated 
complete media containing rIL-2 failed to inhibit growth 
(Figure 13A). However, the activation of cells over seven 
days with rIL-2 could induce inhibitory molecules which 
reduce the growth inhibition of g. albicans. Such 
inhibitors might remain functional during the concentration 
process and inhibit g. albicans growth inhibition. These 
conditions may prevent supernates from demonstrating maximal 
g. albicans growth inhibition. 
The results from these studies demonstrate that cell-
free supernates concentrated 75 fold from rIL-2 activated 
populations stimulated with g. albicans were capable of 
125 
mediating anti-fungal activity, but at a much reduced rate 
when compared to intact rIL-2 activated populations. 
The failure of cellular supernates to mediate 
comparable levels of g. albicans inhibitory activity to 
intact rIL-2 activated populations, lead to the next 
experimental series which assessed the requirement for an 
intact cell population to mediated g. albicans growth 
inhibition. rIL-2 activated populations were disrupted by 
sonication until cells were <99% viable as judged by trypan 
blue exclusion. Of primary interest was whether the 
disrupted cells possessed the ability to mediate the fungal 
growth inhibition. Therefore, rIL-2 activated populations 
used for the sonication experiments were placed in assay 
media at concentrations identical to those for assessment of 
g. albicans growth inhibition without sonication. Following 
sonication, equivalent starting numbers of sonicated rIL-2 
activated populations to control rIL-2 activated populations 
were assessed for g. albicans growth inhibition. The 
sonicated cells of both g. albicans stimulated and 
unstimulated populations produced activity against fungal 
and tumor targets. However only one sixth of the g. 
albicans growth inhibition produced by the intact effector 
population was mediated against g. albicans by sonicated 
cells. The failure of sonicated cells to mediate identical 
levels of growth inhibitory activity against g. albicans 
suggests that the mediator(s) of c. albicans growth 
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inhibition are less effective at inhibiting ~- albicans than 
an intact cell. Previous studies of tumoricidal activity 
have demonstrated granule extracts to be less efficient with 
respect to cytotoxicity than intact cells (Henkart et al., 
1987; Hayes et al., 1989). The limited activity of granule 
extracts may be a consequence of dilution in that the 
activity in solution may be less than that of the intimate 
surroundings of the microenviroment formed by cell to cell 
contact. This effect is overcome by the polarized secretory 
mechanism that delivers a high local concentration of the 
active mediators to the appropriate target site (Hayes et 
al., 1989). Henkart et al., (1987) demonstrated that highly 
purified granules possess higher tumor cytotoxic activity 
than the activity from comparable numbers of unpurif ied 
cellular extracts. The activity of the cellular extracts 
was less than the activity of the intact cells. 
Furthermore, studies of purified NK granules revealed higher 
activity against the fungal target Cryptococcus neoformans 
than those of similarly treated unpurif ied extracts (Hidore 
et al., 1990). 
Limited activity of sonicated rIL-2 activated 
populations in the current study could result from the 
methodology employed. For example, the process of 
sonication may inactivate any ~. albicans growth inhibitory 
molecules. Furthermore, despite the presence of ice during 
sonication, the increase in temperature may inactivate the 
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inhibitory factors. The release of g. albicans inhibitory 
molecules from the stimulated rIL-2 activated populations 
which would otherwise possess enhanced activity might lower 
the potential inhibition. Furthermore, remaining c. 
albicans from the stimulation could alter the results in 
several ways. Remnants of g. albicans sonicated with the 
rIL-2 activated populations may act in a cold target manner 
to bind inhibitory molecules and lower the level of 
observable inhibition. Additionally, the sonicated g. 
albicans may release a variety of factors which may bind or 
inhibit the inhibitory molecules of rIL-2 activated 
populations. These conditions may prevent cell sonicates 
from demonstrating maximal g. albicans growth inhibition. 
Cell sonicates from rIL-2 activated populations 
stimulated with g. albicans were capable of mediating both 
anti-fungal and anti-tumor activity, but at a much reduced 
rate when compared to intact rIL-2 activated populations. 
The finding that rIL-2 activated populations bind g. 
albicans (Figure 12), coupled with the absence of activity 
with sonicates (Figure 13A), and the failure of released 
mediators to affect fungal growth, suggests, but does not 
prove, that cell contact is required for maximal activity 
against g. albicans. 
Based on the above findings, the implication of contact 
mediated activity was further assessed by the use of 
protease inhibitors. Cell surface associated proteolytic 
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enzymes (serine proteases and esterases), have been 
implicated in the lytic phase of the tumor cell cytotoxicity 
reaction (Lavie et g,l. 1985). Complex cellular mechanisms 
triggered by the contact and binding of the target cell via 
the receptor are involved in cellular cytotoxicity. 
Following recognition of a given target cell, the effector 
cell has the ability to activate any or all of several 
proteases which induce the cytotoxic mechanism. Protease 
inhibitors are known to diminish cell-mediated cytotoxicity 
against tumor cells (Jenne and Tschopp, 1987). Therefore, 
the effect of such inhibitors on rIL-2 activated population 
mediated c. albicans growth inhibition was examined. 
Proteases are generally regarded to require cell contact for 
functional activity (Jenne and Tschopp, 1988), therefore, 
the reduced g. albicans growth mediated by protease 
inhibitors in this dissertation implicates a contact 
requirement for maximal g. albicans inhibitory activity. 
Representative protease inhibitors were selected for 
examination because of their differential ability to inhibit 
cytotoxic interactions of tumor targets by various effector 
populations (Lavie et al., 1985; Jenne and Tschopp, 1988; 
Scuderi, 1989). TAME, aprotinin, and PMSF were assessed. 
The concentrations utilized reflect maximum inhibition 
following titer evaluation and did not affect incorporation 
of [3H] uridine by g. a~bicans or affect the viability of 
the rIL-2 activated population utilized for calculation of 
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data. 
Aprotinin inhibited rIL-2 activated cell mediated c. 
albicans growth inhibition as well as tumoricidal activity 
against all targets examined (Figure 10). Aprotinin had a 
lesser capacity to diminish activity against YAC-1 than it 
did against other target cell populations. This could be 
the result of a differential effect on cell populations 
with activity against YAC-1. Aprotinin is a very stable 
molecule which inhibits a variety of enzymes, e.g., trypsin 
and chymotrypsin. Aprotinin binds to the active sites of 
the enzyme, forms a tight complex and renders the enzyme 
inactive (Hewlett, 1990). One model of aprotinin-mediated 
inhibition is through esterase modification in cytoplasmic 
granules (Hayes et al., 1989). The modification of the 
esterase interferes with the regulation of the cytotoxic 
machinery and exocytosis of cellular constituents there by 
inhibiting cytotoxicity (Hayes et al., 1989; Lavie and 
Zucker-Franklin, 1989). In the current study, the~. 
albicans inhibitory activity as well as the tumor cytotoxic 
activity is not completely eliminated by the effect of 
aprotinin. This may be as a result of incomplete saturation 
within the area of cell contact. However, concentration 
dependant evaluations failed to lower the remaining ac-
tivity. Alternatively, the lack of inhibition may also be 
due to other cytotoxic mechanisms which are not inhibitable 
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by aprotinin. Such mechanisms might be responsible for the 
residual ~. albicans growth inhibition of the rIL-2 
activated populations. 
PMSF inhibited the activity of rIL-2 activated 
populations against P815 and ~. albicans, but not YAC-1. 
PMSF has been reported to inhibit activity of both T cells 
and NK cells (Jenne and Tschopp, 1988). PMSF has been 
demonstrated to inhibit target cell DNA release by 
inhibiting a serine protease activity that resides in a low 
pH subcellular compartment, believed to be granzyme A (Hayes 
et al., 1989). Previous studies by that group have also 
demonstrated that PMSF substantially inhibits BLT esterase 
activity (Henkart et i!l., 1987). Whether PMSF is inhibiting 
either of these proteases in this study is unknown. The 
ability of PMSF to numerically inhibit growth of ~- albicans 
and cytotoxic activity against P815 but not YAC-1, does 
suggest a similar population or mechanism of activity is 
active in mediating anti-~. albicans and anti-P815 activity, 
but not necessarily anti-YAC-1 activity. The inability of 
PMSF to reduce activity against YAC-1 might result from 
other cytotoxic populations which are not sensitive to PMSF. 
PMSF is slower to react with active sites of enzymes than 
aprotinin and is very susceptible to spontaneous hydrolysis 
and loss of activity (Gebhard et al., 1986). The activity 
of this relatively unstable molecule may have been altered 
during use and may contribute to the limited activity. 
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TAME failed to mediate any effect against either tumor 
targets or &· albicans. While TAME may inhibit other 
proteases it has been specifically shown to inhibit the 
release of TNF from rIL-2 activated lymphocytes (Scuderi, 
1989), and TNF mediated cytotoxicity (Suffys et al., 1988). 
Therefore, TNF most likely is not involved in the mechanism 
of growth inhibition of &· albicans. This was not 
unexpected, for previous reports have shown TNF activity 
requires a longer time frame for tumor cytotoxic activity 
than the short term (four hour) assays utilized in these 
studies (Old, 1985; Havell et al., 1988). Furthermore, 
previous studies have failed to demonstrate anti-&. albicans 
activity of TNF (Djeu et al., 1988). The observations with 
TAME are consistent with those findings. 
Effector cells pretreated and washed of protease 
inhibitors failed to alter the normal cytotoxic and 
inhibitory activity of rIL-2 activated populations. These 
findings are supported by previous studies (Lavie et al., 
1985). These findings are also consistent with the model 
proposed by Lavie in which surf ace-associated proteolytic 
enzymes that are concealed from the external environment 
become exposed during cytolysis and participate in target 
cell damage (Lavie et al., 1985). The model and results 
suggest that only within the contact microenviroment are the 
protease inhibitors active, further implying contact may be 
essential to the activity of rIL-2 activated populations. 
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This dissertation has demonstrated that ~. slbicans 
growth is inhibited by a population of rIL-2 activated 
lymphocytes. According to Granger and Hobbs (1988), 
demonstration of the following criteria are required for 
indisputable proof that a cell population functions in 
defense against a fungal agent: 1) a recognition step occurs 
in which the effector cell forms a conjugate with the target 
cell; 2) contact-dependent interaction results in target 
cell killing or growth inhibition; 3) purified effector or 
cell molecules are cytotoxic or cytostatic for the 
microorganism; 4) experimental animals made specifically 
deficient in the effector cells show enhanced susceptibility 
to the microorganism; and 5) enhanced host susceptibility 
can be abrogated by adoptive transfer of effector cells. 
By these criteria, several sets of experiments must be 
completed prior to absolute proof that rIL-2 activated 
populations mediate anti-fungal activity. Upon the 
completion of such studies, the role of rIL-2 activated 
populations in ~- albicans inhibitory activity will be 
answered. Until such time, the function of rIL-2 activated 
populations in mediating c. albicans growth inhibition 
remains speculative. 
The definition of the rIL-2 activated population as a 
biological activity and/or function against the hyphal phase 
of ~. albicans does not address its immunological nature. 
These studies strongly suggest that the rIL-2 activated 
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population is not an NK or an activated NK population due to 
the failure of these populations to mediate g. albicans 
growth inhibition (Figures 1, 2, and 3). Additionally, rIL-
2 activated lymphocytes expressing NK 1.1 fail to mediate g. 
albicans growth inhibition (Figure 11). In contrast, rIL-2 
activated populations do possess several characteristics of 
rIL-2 activated cytotoxic lymphocytes including; broad 
spectrum target cell activity, phenotype, and LGL 
morphology. The phenotypic expression of Thy-1.2+ and ASGM-
1+ within the rIL-2 activated population, and Lyt-2.2+ 
within the rIL-2 activated population directly parallels LAK 
phenotypic expression (Mule et al., 1989). rIL-2 activated 
populations are clearly a lymphokine activated cell 
population. Whether they are a lymphokine activated killer 
cell (LAK) population or a subset of LAK is unclear. 
However, by essentially any definition, the anti-tumor 
activity of the lymphocyte population is LAK (Merluzzi et 
al., 1986; Mule et al., 1989). Various studies have 
revealed substantial heterogeneity in LAK cell activity 
following activation with rIL-2. The lytic activity of 
various types of LAK and their apparent specificity are 
highly dependent upon their state of activation. rIL-2 may 
alter the reactivity of LAK populations, and the high levels 
of rIL-2 utilized in this study may induce the g. albicans 
growth inhibition. No reports have previously demonstrated 
g. albicans growth inhibition or anti-fungal activity for 
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LAK populations. 
The data presented in this study are the first to show 
that rIL-2 activation of splenocytes results in a population 
of lymphocytes capable of affecting the growth of ~. 
albicans in vitro. This study is consistent with previous 
investigations (Vecchiarelli et al., 1985; Djeu and 
Blanchard, 1987) but demonstrates that higher concentrations 
of rIL-2 are required to obtain a splenocyte population 
capable of affecting the growth of the fungus in vitro. 
Whether this phenomenon functions in vivo, as a form of host 
defense, has yet to be established. It is possible that the 
elaboration of rIL-2 or other cytokines and the concomitant 
induction of activated lymphocytes may indeed serve as a 
line of defense against ~. albicans. Protection of the 
mammalian host against this form of fungal disease may at 
least in part account for the resistance of the C57Bl/6 
mouse to challenge with the microorganism. Furthermore, 
these cells may serve as potential effectors during the 
development of fungal infections and may be considered as a 
possible therapeutic means by which to limit fungal 
infections in immunocompromised individuals. 
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CONCLUSIONS 
1) Splenocytes activated with rIL-2 inhibit the growth of 
fungi, in vitro. They are cos+ lymphocytes which must 
be activated with rIL-2 to exhibit fungal growth 
inhibition. 
2) Optimal growth inhibition of fungi is mediated by 
intact lymphocytes, through a surface-active, serine 
protease. 
3) Growth inhibition of fungi does not appear to be 
mediated by natural killer cells or activated natural 
killer cells. 
4) ~. albicans growth inhibition by rIL-2 activated cell 
populations is associated with enhanced tumoricidal 
activity against the NK resistant cell line YAC-1 and 
the NK resistant cell line P815, suggesting broad 
reactivity for heterogenous targets by rIL-2 activated 
cell populations. 
5) The rIL-2 activated population which possess ~. 
albicans growth inhibitory activity does not 
necessarily possess anti-P815 activity despite 
correlative phenotypic, binding and cell associated 
protease susceptibility. 
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